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Janet Gavin Knecht, PhD
University of Connecticut, 2014
Although prescription medication adherence has been studied in the Heart Failure
(HF) population, little attention has focused on the patient’s overall medication practices
including over the counter medications and their confidence in following their prescribed
therapeutic regime. The primary aim of this study is twofold: 1) Measure and gain a more
complete understanding of HF medication management self-efficacy and 2). Quantify
self-medication practices. Patients with HF live with the certainty that their quality of life
depends on the proper management of multiple medications and innumerable therapeutic
regimes. Failure to properly manage prescription medications increases the risk of
exacerbation of HF and increased rates of rehospitalization. The prevention agenda for
the United States, Healthy People 2020, calls for identification of the most significant,
preventable threats to US health and establishes national goals to reduce these threats.
This project identifies adverse medication practices in patients with HF, a significant
threat to the health of the nation's older adults. Older adults have significant knowledge
deficits with respect to interactions of prescription and over the counter (OTC)
medicines. This mixed-method study employed a convergent parallel mixed-methods
design (Creswell & Plano Clark, 2011). A telephone interview was used to complete the
ActualMeds™ and HF medication self-efficacy instrument. Concurrently, qualitative
interviews are conducted on the patients who scored high and low on HF medication selfefficacy to discover their perspective of their therapeutic regime. The qualitative

interviews inform the researcher and validate the data from the quantitative strand
providing greater depth to the process of patients’ self-medication practices and
adherence along with self-efficacy when living with HF. Data reveal that polypharmacy
is pervasive and patients are prescribed medications not recommended for the
geronotologic population and / or risk anticholinergic burden. Future study is required to
enhance this technology to provide seamless communication between providers and
patients to decrease the risk to patients.
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Running Head: PATIENTS AND HEART FAILURE MEDICATIONS
Chapter 1
Introduction
Defining the Problem
Heart failure (HF) is a major public health problem in the United States. It is
defined as a clinical syndrome that results from any structural or functional disorder that
decreases the ability of the ventricles to fill or eject blood. HF is diagnosed from a myriad
of symptoms that result in dyspnea and fatigue (Yancy et al., 2013). More than five
million people have been diagnosed with HF, and more than 650,000 people are
diagnosed each year (Yancy et al., 2013). Approximately 5.7 million Americans are
living with HF in this country(Roger et al., 2012). The cost of HF was sustained at almost
35 billion dollars annually from 2008 to 2011(Heidenreich et al., 2013) and more
Medicare dollars are spent on the primary diagnosis of HF than any other diagnosis
related group (Jencks, Williams, & Coleman, 2009; Zhang, Rathouz, & Chin, 2003). HF
is responsible for over one million admissions annually and is the most common cause
for hospital admission in persons over 65 years of age. A hospitalization stay usually lasts
7-10 days (Jencks, Williams, &Coleman, 2009). Patients with HF have the highest
readmission rates, most often within weeks of discharge (Hernandez et al., 2010). Finally,
HF carries a 50% mortality rate in 5 years (Go et al., 2014).
HF has been labeled a cardiovascular disorder of aging with the incidence
approaching 10 per 1000 after 65 years of age. More than half of all patients diagnosed
are over the age of 75 (Falk, Ekman, Anderson, Fu, & Granger, 2013; Go et al., 2014).
Sixty-nine percent of total HF expenditures in 2012 were used to treat patients ≥ 65 years
of age (Heidenreich et al., 2013).
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Failure of older adults (≥65 years) to take medications properly is estimated to be
a factor in more than one quarter of emergency department (ED) visits (Budnitz et al.,
2006) Upon admission, medication reconciliation records are often inaccurate (Balon &
Thomas, 2011; Gurwitz et al., 2003). Medication nonadherence in the HF population is
associated with an increased risk of all-cause mortality and cardiovascular
hospitalizations (Fitzgerald et al., 2011; Wu, Moser, Chung, & Lennie, 2008; Wu, Moser,
De Jong, Rayens, Chung, Riegel, et al., 2009). Failure of the healthcare system to identify
and remediate poor adherence and adverse self-medication behaviors adds to the overall
cost of treatment as providers typically intensify antihypertensive and HF therapy and
add additional agents to the regimen further increasing the risk of adverse drug side
effects as well as cost (Jencks, Williams, &Coleman, 2009; Ho, et al, 2008; Peterson,
2008). Seventy-three percent of HF patients have HTN upon admission to the hospital
(Fitzgerald et al., 2011). An estimated $100 billion is spent annually in the United States
on health care for patients with poorly controlled BP in part due to poor antihypertensive
medication adherence and other adverse self-medication behaviors (Institute of Medicine,
2010). Uncontrolled hypertensive HF leads to high rates of intensive care admission,
prolonged hospitalization, and increased 90-day readmission (Jencks, Williams, &
Coleman, 2009; Peacock et al., 2011; Hernandez et al., 2010).
Background and Significance
The prevention agenda for the United States (US), Healthy People 2020, calls for
identification of the most significant, preventable threats to US health and establishes
national goals to reduce these threats. This project identifies adverse self-medication
practices in patients with HF, a significant threat to the health of the nation's older adults.
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Older adults have significant knowledge deficits with respect to interactions of
prescription and over the counter (OTC) medicines, and have low self-efficacy levels in
how to avoid serious interactions (Neafsey & Shellman, 2002a). The project also
promotes patients’ rights delineated by the Institute of Medicine (2010) to: 1) be the
primary source of control for all medication management decisions that affect them, 2) be
adequately informed about their medication therapy and alternative treatments.
Patients with HF live with the certainty that their quality of life depends on the
proper management of multiple medications with potential interactions, and also
innumerable therapeutic regimes. Failure to properly manage prescription medications
increases the risk of exacerbation of HF and increased rates of rehospitalization
(Fitzgerald et al., 2011; Wu, Moser, Chung, & Lennie, 2008; Wu, Moser, De Jong,
Rayens, Chung, Riegel, et al., 2009). Although prescription medication adherence has
been studied in the HF population, little attention has focused on the patient’s overall
self-medication practices including OTC medications and their confidence in following
their prescribed therapeutic regime.
Purpose
This mixed methods study addressed medication practices and HF management
self-efficacy. The study used a convergent parallel mixed-methods design (Creswell &
Plano Clark, 2011). Quantitative data was collected on each patient diagnosed with HF,
> 50 years old, and recently discharged from home care following hospitalization for any
cause. Following descriptive quantitative data collection, an in depth qualitative interview
was conducted on patients who scored higher (≥ 4) and lower (≤ 3) in HF medication
self-efficacy. This quantitative component was meant to produce a more complete
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understanding of the qualitative results. A telephone interview was employed to collect
data via an online instrument that guided a structured interview by the principal
researcher. The primary aim of this study was twofold: 1) measure and gain a more
complete understanding of HF medication management self-efficacy and 2) quantify selfmedication practices. Immediately following the completion of the quantitative
interviews, qualitative interviews were conducted to discover the patients’ perspective of
their therapeutic regime. The results of these quantitative interviews were meant to
inform the researcher and provide insight into the qualitative strand. It was to provide
greater understanding and depth to the process of patients’ self-medication practices and
adherence along with self-efficacy when living with HF.
Research Questions
Quantitative: What are the HF medication self-efficacy scores of patients following his/
her HF medication regime?
What are the self-medication practices of patients living with HF?
What is the relationship between self-efficacy scores and the number of medications or
risk score of HF patients in this study?
Qualitative: What are the themes described by patients living with HF who score high
and low measures on a HF medication self-efficacy instrument?
Mixed-Methods: To what extent do the quantitative scores of patients living with HF,
who scored high and low in self-efficacy, inform the themes derived from qualitative
interviews?
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Methodology Worldview: Pragmatism
The philosophical foundation of the mixed methods approach to research is
pragmatism (Creswell and Tashakkori, 2007). Truth is discovered through the test of
usefulness. Within a pragmatic approach, one recognizes that there is both “a single ‘real
world’ and that all individuals have their own unique interpretations of that world”
(Morgan, 2007, p. 73). It evolved from the constructivist perspective, which sought to
describe a problem within the social political landscape (Morgan, 2007). Mixed methods
research blends the singular and multiple views of reality (Creswell & Plano Clark,
2011). Morgan (2007) advocates that the abduction-intersubjectivity-transferability
approach provides an opportunity to “move back and forth between”(p. 71) the
induction/deduction and subjectivity/objectivity throughout the research process. It is
through this working back and forth between the theory and approaches to knowledge
that the depth of the pragmatic approach is discovered. Ultimately, Morgan (2007)
suggests an emphasis on “abduction, intersubjectivity, and transferability” promotes new
opportunities for methodologic perspectives in research.
Definition of Essential Concepts
Heart Failure
HF is a complex condition that results from structural or functional disease.
Ultimately, it decreases the ability of the ventricles to fill or eject blood and results in
dyspnea and fatigue (Yancy et al., 2013). Evolving over the past decade is the
identification of two distinct etiologies resulting in HF. Long recognized and most cited
in the literature, is left ventricular systolic abnormalities resulting in reduced left
ventricular ejection fraction (HFrEF). More recently, a form of HF has been identified
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with preserved left ventricular ejection fraction (HFpEF) in which the abnormality occurs
during diastole resulting in decreased filling (Yancy et al., 2013). The American College
of Cardiology (2013) has defined both etiologies and has recognized that presentation and
treatment required differ (Table 1). However in its staging of the severity of HF, the
American College of Cardiology defined HF by the degree of left ventricular impairment.
Investigating the recommendations further, it is clear that the preponderance of evidence
supporting the treatment of HF is based on the study of decreased left ventricular ejection
fraction. (American College of Cardiology, 2013). While 11 of the 12 Class I
recommendations for treatment of left ventricular systolic function are supported by level
A or B evidence, the evidence supporting the treatment of preserved systolic function is
noted briefly and supported by level C evidence.
Self-Medication Practices
Self-medication practices are patient self-reported data on use of prescription and
OTC medications, nutrition and herbal supplements, alcohol and tobacco. Dose,
frequency, and timing of administration of these agents were entered into the
ActualMeds™ system and analyzed by the software designed for this purpose and
previously validated (Neafsey et al., 2011). A Risk Score calculated by the rules engine
was used as a measure of patient status.
Self-Efficacy Score
Bandura (1982) described two constructs used in self-efficacy theory: self-efficacy
expectations and outcome expectations. He defined self-efficacy expectations as an
individual’s perceived ability to successfully complete the task. A proposition of self-
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efficacy theory is that self-efficacy expectations change over time with experience and
the opportunity to develop skills. It is an adaptive process. The construct of outcome
expectations endorses that if a behavior were mastered, a desired outcome would result.
Propositions related to outcome expectations and self-efficacy expectations differ in that,
a person may expect that a certain outcome will result from a certain behavior, but not
have confidence in his/ her own ability to complete the task. Prior to this study, the HF
Medication Self-Efficacy Instrument (Knecht, 2012) was developed to assess these
outcomes and validity was established. A score for each concept is derived from the
patient responses.
Summary
This chapter has defined the problem, background and significance that patients
living with HF face in their daily management of their medication regime. It has also
stated the purpose and proposed the research questions. Essential concepts that will be
examined throughout the paper, including HF, self-medication practices, and self-efficacy
score were defined.
HF has a significant impact on patients’ lives. With the population of the US
aging, more people are living with this syndrome. The healthcare team must be cognizant
of the problem of polypharmacy and the myriad of interactions that result from this
practice. The data resulting from this research will substantiate the problem of
polypharmacy and inform nurses of patients’ perceptions of living with the medication
regime that HF carries.
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Chapter 2
Theoretical Framework and Review of Literature
This chapter presents Bandura’s Social Cognitive Theory of Self-Efficacy
(Bandura, 1977). It describes the foundational assumptions, definition of concepts, and
the essential constructs. It reports pertinent nursing research that has employed SelfEfficacy theory for specific populations and instruments that have been developed for
these populations. This chapter also presents the review of current literature. A search of
the English language literature was conducted using online reference databases from
1990-2014. CINAHL Plus with Full Text, PubMed, Scopus, PsycINFO and Dissertation
Abstracts were searched using the keywords HF, qualitative, experience, symptoms,
quality of life, and self-care.
Self-Efficacy
Self-efficacy theory has been derived from social cognitive theory, a theory that
attempts to explain and predict behavior (Bandura, 1977). Social cognitive theory is
based on three paradigmatic concepts: behavior, cognitive factors, and environmental
influences. These concepts form the basis of the model with the relationship of triadic
reciprocal determinism. The three concepts interact bidirectionally, but not necessarily
equally.
Self-efficacy theory is a psychologic theory that must be evaluated on its ability to
improve the lives of individuals. As it has been adapted to nursing, interventions are
designed to promote health and to improve the lives of patients in many settings. Selfefficacy theory states that a person’s judgment of his or her capabilities to organize and
execute courses of action will determine behavior. The goal is not to provide care but
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facilitate the patient to view a successful outcome. One of the underlying assumptions is
the freedom of the individual to decide behavior (Bandura, 1977). A philosophic
component of self-efficacy theory is free will. However, within free will, the theory
recognizes that most behavior is related to a myriad of factors that ultimately influence
behavior.
Self-efficacy theory is based on several underlying assumptions. Individuals have
some influence on their actions and this intentionality is described as personal agency.
This influence does not guarantee control of outcomes. Most behavior is related to
countless factors, which infers the possibility of many outcomes. In order for individuals
to develop self-efficacy, they must be able to self-evaluate. In comparing themselves to
some evaluative process, individuals determine their likelihood of success. Finally, one
last underlying assumption of self-efficacy theory is individual freedom; that is, the
ability to decide how to behave. Freedom is an underlying value in our culture; Bandura
(1982, 1997) rejects the assumption that behavior change is an inborn drive.
Concepts
Human agency (person) is an individual’s action toward a purpose; that
is, individuals conceive of an idea to act, analyze the perceived consequences of the act,
and choose whether or not to complete the actions. Individuals draw on prior experience
to make their choices. Human agency has been derived from social cognitive theory and
functions within the framework of triadic reciprocal causation. Again, the triad consists
of cognitive, behavioral, and environmental influences and these concepts interact
bidirectionally to influence outcomes (Resnick, 2009). At different times, any one
concept might have more influence on the outcome than another concept. For the
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population of patients living with HF, patients self evaluate the benefit of self-care
practices. There are facilitators and barriers.
Self-efficacy expectations is a construct defined as an individual’s perceived
confidence in his/ her ability to successfully complete the task (Bandura, 1982). A
proposition of self-efficacy theory is that self-efficacy expectations change over time
with experience and the opportunity to develop skills. It is an adaptive process. Outcome
expectations are based on a person’s self-efficacy expectations; that is, if one has high
self-efficacy, she will expect a successful outcome (Bandura, 1982). The proposition
related to outcome expectations endorses that if a behavior were mastered, a desired
outcome would result. Alternatively, propositions related to outcome expectations and
self-efficacy expectations differ in that, a person may expect that a certain outcome will
result from a certain behavior, but not have confidence in her own ability to complete the
task. Additionally, in relation to HF, a person might believe that she is able to execute the
task; however the patient might not believe that it will provide any benefit (low outcome
expectations).
Within self-efficacy theory are four sources of self-efficacy information: enactive
attainment, vicarious experience, verbal persuasion, and physiologic feedback. Enactive
attainment, which is also referred to as enactive mastery, is the knowledge that
performing an activity strengthens self-efficacy (Bandura, Adams, Hardy, & Howells,
1980). Vicarious experience is the belief that seeing others around you succeed at a task
will increase your self-efficacy. Verbal persuasion is the power of influencing a
participant’s behavior through verbal persuasion (Bandura, 1977). Within the theory of
self-efficacy, Verbal persuasion is also sometimes referred to as verbal encouragement.
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Persuasion and encouragement could be viewed quite differently in clinical situations.
Finally, physiological feedback states that an individual’s self-efficacy is influenced by
her physiologic state. Improved feelings of the patient will provide positive feedback that
will enhance a favorable transition to living with HF.
There is no direct relationship between person, environment, and behavior (Figure
1). All arrows are unidirectional, moving out from the four sources of information. This
theory proposes that self-efficacy expectations are impacted by the person, environment,
and the four sources of information. Outcome expectations are impacted only by the
person and information sources. Self-efficacy expectations and outcome expectations in
turn influence behavior. It is adaptive and changes over time. For this study, transition
was added to Bandura’s model to represent the patient’s transition through the process of
living with HF.
Transition is a process that transpires with changes in our lives. Meleis, Sawyer,
Im, Messiaas, and Schumacher (2000) suggest, “vulnerability is related to transition
experiences, interactions, and environmental conditions that expose individuals to
potential damage, problematic or extended recovery, or delayed or unhealthy coping” (p
12). At times of illness, patients are compelled to confront their symptoms and challenges
they pose within the framework of their social support systems. Meleis et al. (2000)
suggest there are both facilitators and inhibitors to transitions.
The model does not represent any feedback; however, feedback is reflected in the
theory description. Within the definition of the concept of human agency is the
assumption that individuals draw on prior experience to make decisions related to
behavior. A proposition is that self-efficacy expectations change over time with
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experience and the opportunity to develop skills. There is an element of pragmatism in
the patient’s evaluative process. As the patient develops self-efficacy and outcome
expectations, he/she evaluates his/ her own ability to successfully complete the task.
Studies have supported the proposition that interventions designed to reinforce the four
sources of knowledge promote the adoption of healthy behavior choices.
Research on Self-Efficacy
Self-efficacy theory was developed as a psychologic theory and has been adapted to
nursing research for the gerontologic population by Resnick (Resnick, 2000; Resnick et
al.,2006; Shaughnessy, Resnick, & Macko, 2005), Perkins and Jenkins (1998) in the area
of cardiac nursing, and Lin and Ward (1996) in pain management. Self-efficacy theory
has been adapted to transcultural care (Jeffreys & Smodlaka, 1999) and health promotion
practices (Adderley-Kelly & Green, 2000). Self-efficacy theory continues to be used
across disciplines to promote behavior change (Marks, Allegrante, & Lorig, 2005a;
Marks, Allegrante, & Lorig, 2005b; Linde, Tothman, Baldwin & Jeffery, 2006; Neafsey
et al., 2011).
Tests of concepts and their interplay are measured by instruments developed
within different areas of research. Bandura proposed that self-efficacy is situation or
behavior specific. Different instruments to measure self-efficacy in older adults, specific
to a task and adapted for each population have been developed (Resnick & Jenkins,
2000). Bandura developed a standard instrument which included a 100 point Likert scale,
divided into 10-unit intervals, used to rate a participant’s confidence in performing a task:
zero being completely uncertain, to 10, being completely certain. This scale has been
used extensively. Resnick has adapted the scales she has created to have nine-unit
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interval items to measure with a five point Likert scale to rate a participant’s confidence
at performing the task: one representing strongly agree, to five, representing strongly
disagree. Her Self-Efficacy for Functional Ability (SEFA) scale (Resnick, 1999)
randomly ordered the items in the nine item scale as opposed to Bandura’s procedure of
ordering tasks from easiest to most difficult (Bandura, 1997). Although there was no
empirical difference in self-efficacy related to ordering of items, Resnick began to test
instruments for each situation. She also developed the Self-Efficacy for Osteoporosis
Medication Adherence (SEOMA) scale (Resnick, Wehren, & Orwig, 2003) and the
Outcome Expectations for Exercise (OEE) (Resnick & Spellbring, 2000). For this current
study, the HF Medications Self-Efficacy instrument was developed and previously
validated (Knecht, 2012).
A patient may see his/her outcome expectations improve if his/her environment is
more conducive to change and therefore have improved self-efficacy. Health is a
dynamic state that can be impacted by behavioral decisions. This project aims to discover
the constructs that patients describe that enhance their ability to care for themselves and
believe that their medications provide some benefit. Furthermore, it is important to
determine that patients may present high levels of confidence to providers yet exhibit
multiple adverse medication and lifestyle behaviors. It is essential that researchers
understand the patient’s perspective in order to design interventions to support them and
improve their overall SE.
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Review of Literature
Quantitative Issues of Self Medication and Self Care
Studies were found that addressed prescription medication adherence (Wu et al.,
2008; Wu et al., 2009; Cooper et al., 2009; Bohm et al., 2013) and adherence to medical
advice (Powell, et al., 2010; Lama Tamang, Tang, Chuang, Patel, & Wong, 2013) in the
HF population. Wu et al. (2008) first sought to describe predictors of medication
adherence in HF. The population was drawn from a busy HF clinic in Kentucky and
included 70% men with ischemic etiology. The authors used the World Health
Organization’s multidimensional adherence model to measure three indicators: dosecount, the percentage of prescribed dosed taken; dose-days, the percentage of days the
correct number of doses were taken; and dose-time, the percentage of doses taken at the
prescribed time. They cited barriers to each measurement with perceived social and
financial support as having the greatest impact.
In a follow up study, Wu et al. (2009) sought to identify at what point the degree
of medication adherence impacts current HF status, rehospitalization, and morbidity.
They conducted a longitudinal study (3.5 years) of 135 participants with HF. They used
the Medication Event Monitoring System (MEMS) to identify dose count and dose days.
MEMS is considered a test standard for the measurement of medication adherence and
employs an electronic chip to record the date and time the cap is removed from the
medication bottle. Patients were also given a medication diary in order to remove
openings for other reasons, for example to refill the bottle. Outcome data analysis
consisted of a series of Kaplan-Meier plots with log-rank tests, Cox regression analyses,
controlling for age, gender, ejection fraction, New York Heart Association, ACEI use and
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B-blocker use. They concluded that patients were significantly more event free when
adherence to the prescribed regime was >88%.
(Albert et al., 2013)revealed that patients seeking emergency care for HF
decompensation demonstrated inaccurate HF beliefs and poor self-care adherence.
Participants included 195 adults living with HF who presented to the ED for
exacerbation. Validated instruments for HF illness beliefs and self-care adherence were
used. Illness beliefs are based on a perceived level of danger by the patient and determine
how he will cope. There was a lack of association between HF beliefs and self-care
adherence, which reflects a need for improved HF education.
Mahramus et al. (2013) sought to discover nurses’ knowledge of HF to determine
the effectiveness of their discharge education for the complex regime. Nurses (n = 90)
completed an online test of HF knowledge using an instrument developed for this
purpose that was previously validated. Only 8.9% of nurses achieved a passing score of
85%.
Bohm et al. (2013) studied the effects of nonpersistence of study medications, 80
mg telmisartan daily as compared with 10 mg ramipril, on outcomes and events
associated with nonadherence on patients with cardiovascular disease. Patients enrolled
in the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint
Trial (ONTARGET) were compared (n = 20,991) with patients who had permanently
stopped study medications (n = 4,629). Nonpersistence in HF was associated with death,
myocardial infarction, stroke, and hospitalization (p < .001). Nonpersistence was also
associated with older age, female gender, less physical activity, less education, and
history of stroke/transient ischemic attack, depression, and diabetes.
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Lama Tamang, Tang, Chuang, Patel, and Wong (2013) studied 371 patients with
HF to describe risk factor control and adherence to recommended therapies. In patients
living at home, only 16. 7% were taking all four of the ACC recommended four classes
of drugs [β-blockers, angiotensin converting enzyme inhibitors/angiotensin receptor
blockers (ACEIs/ARBs), diuretics, and digoxin]. A majority (83.3%) were taking only
one drug of the recommended 4-drug regimen. Additionally, only 69.1% were at goal for
blood pressure. The authors concluded a significant gap between adherence to medication
regime and control of significant risk factors in the population of HF patients living at
home.
Cooper et al. (2009) sought to identify prescription medication adherence in
patients from both employer groups and health plan groups for a subset of diagnoses
groups: coronary artery disease, hypertension, HF, diabetes mellitus, and hyperlipidemia.
They used eligibility data and administrative pharmacy claims as the data source. Claims
were reviewed for a 12-month period in 2007. The HF group represented eight percent of
the total population studied. Medication adherence with angiotensin converting enzyme
inhibitors was 76.2% in the employer group and 80.6% in the health plan group. Other
medication groups reported on were b-blockers at 81.5% for the health plan group and
76.5% for the employer group, angiotensin receptor blocker at 81.0% and 75.2%
respectively, and diuretics at 78.2% and 75.5% respectively. The authors identify an
important next step is to understand the factors that influence adherence behavior.
Toh, Jackson, Gascard, Manning, and Tuck (2010) sought to identify barriers to
prescription medication adherence during home visits of patients with HF and propose
possible solutions to these problems. They conducted a descriptive study of home visits
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of patients with HF by pharmacists consulted as part of a multidisciplinary team. A total
of 66 patients were observed in the study and barriers to medication adherence and
subsequent interventions were recorded. Interventions included education, counseling,
motivational interviews, and reducing dosing frequency. Poor or complex medication
instructions was cited by 71% of patients, 33% cited running out of medications and 20%
reported adverse drug reactions. Multiple strategies were necessary to overcome barriers.
(Dunlay, Eveleth, Shah, McNallan, & Roger, 2011)studied 209 patients with HF
to determine factors associated with poor adherence, which was defined as the proportion
of days covered (PDC) less than 80%. The median number of medications in the
population was 11 (interquartile range, 8-17) with 26 patients (12%) filling more than 20
medications. Nineteen percent of patients had poor adherence to B-blockers and
ACEIs/ARBs. Patients with poor adherence to ACEIs/ARBs were younger (p <.05) and
men had lower ACEIs/ARBs adherence than women (p <.04). Cost related to statin
medications was the most often cited issue by patients for this category. Other factors
cited included prior history of depression, marital status, and dosing frequency of
medications.
Delaney, Apostolidis, Bartos, Morrison, Smith, & Fortinsky (2013) conducted a
randomized control trial that included both telemonitoring and self-care education
interventions for 93 patients to determine if these variables impacted rehospitalization
rates, knowledge scores and quality of life (QOL). The primary outcome of 90-day
rehospitalization post-home care discharge was significantly reduced in the intervention
group (p < .046). HF knowledge (p < .013) and QOL (p < .004) were significantly
increased in the intervention group as compared to the control group.
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Buck et al. (2012) sought to describe the relationship between self-care and healthrelated quality of life (HRQOL) in older patients (≥65 years) with moderate to severe
HF. Self-care was measured using the Self-care of HF Index, which was previously
validated. HRQOL was measured using the Minnesota Living With HF Questionnaire.
Pearson correlation, independent-samples t-tests, and linear and logistic regression were
used in analysis of the data. The authors concluded that confidence in HF self-care is
related to HRQOL and interventions to improve confidence would be beneficial in older
adults living with HF.
None of the quantitative studies incorporated potential adverse drug interactions
between prescribed medications and OTC medications that patients confront upon
dealing with a diagnosis of HF; nor did they try to discover an understanding for the
medication behaviors of patients. For a deeper understanding of patients, the researcher
turned to qualitative research. Studies were discovered that sought to explain and
describe what it is to live with HF. Upon closer inspection, the majority of these studies
used quantitative methods to answer a research question related to one facet of the
experience of living with HF. Of those that were qualitative, most were excluded since
they did not relate to the aim of this study.
Qualitative issues of Living with HF
Whitty, Carrington, Stewart, Holliday, Marwick, and Scuffham (2011) conducted a
pilot study to discover patients’ preferences with HF management program. No
philosophic worldview or theoretical framework was mentioned to guide the study. A
purposeful sample of 12 patients were interviewed and themes drawn from NVivo 8
included patients’ perception of the value of the program beyond those related to health,
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social and peer support, other themes related to barriers in participating in the clinic,
transportation, cost, and ill health. The authors concluded that in-home delivery of HF
management programs was necessary for this population.
Thornhill, Lyons, Nouwen, and Lip (2008) conducted an interpretive
phenomenological study in both outpatient and inpatient units at a metropolitan hospital
to improve the understanding of patients living with HF. Semi-structured interviews were
completed on 25 patients; 21 were men. Although medication adherence was not the
focus, four themes were identified: the diagnostic process, change in activities, the role of
others, and emotional reactions. The authors concluded that interventions to promote selfcare would benefit this population.
Waterworth and Jorgensen (2010) conducted a descriptive qualitative study to
describe the process living with a new diagnosis of HF. The 25 patients interviewed were
ages 70-90 years (15 men, 10 women) and were newly diagnosed with New York Heart
Association classes II-IV HF. Interviews were conducted in participants’ home every
three months for a 12-month period. The 79 interviews with 25 people and were
transcribed verbatim. NVivo 8 was used for analysis of reoccurring themes. Their
findings suggested that the transition was not a linear process, rather an experience of
complexity, forward and backward and required further study to provide the resources
and education necessary to ease the transition.
Dickson, Buck, and Riegel (2011) sought to discover how comorbidity influences
HF self-care in a qualitative meta-analysis. They cite Noblit and Hare (1988) but cite few
of the steps of meta-ethnography; however, they also discuss Byrne’s (2001) strategies
for qualitative research and approaches to meta-analysis (McCormick, Rodney, &Varcoe,
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2003). They examined and analyzed transcripts from three mixed methods studies
(n=99). The authors described themes about the perception of HF and self-care and
explore the influence on HF self-care. Self-care was defined as adherence to diet,
symptom monitoring and differentiating symptoms. Themes included 1) attitudes drive
self-care and 2) fragmented self-care instruction leads to poor self-care integration of
self-care skill deficits. The authors concluded that research testing coaching, with
integration of self-care and a focus on developing skill in self-care, was warranted.
Crowder (2006) sought to explore what influences patient attendance and
continued participation in a HF clinic. She conducted an ethnographic qualitative study.
Her study included 15 participants from a HF clinic in Arkansas, including 11 women,
five of whom were widowed, 73% were married. She conducted audiotaped interviews to
uncover influences on enrolling and continued participation in the HF clinic. Results the
author identified as beneficial influences were a sense of belonging and education;
identified as barriers were travel and cost.
Gary (2006) conducted a descriptive study to describe the performance of selfcare behaviors and demographic and symptom characteristics that impacted self-care
practices. Thirty-two women, diagnosed with diastolic HF were recruited from a busy HF
clinic to participate in the study. Data was collected using semi-structured interviews.
Descriptive statistics were used to analyze the data. Although participants felt that they
had a good level understanding of prescribed self-care practices, only 19% weighed
themselves daily, few followed sodium guidelines and 91% were not exercising. Seventytwo percent of participants followed their medication regimes. Poor socioeconomic status
was found to increase vulnerability to poor clinical outcomes. Women in this bracket
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were more likely to delay medication refill, which resulted in hospitalization in several
cases. The authors concluded that current HF clinic education was not enough to impact
self-care practices in this population.
Mixed Methods Research
Two mixed-method studies were discovered on patients living with HF. Dickson,
Lee, and Riegel (2011) conducted a concurrent triangulation mixed method study to
explore how knowledge and cognitive function impact self-care. Interviews were
conducted on 41 adults with HF on self-care practices. This was followed by completion
of standardized instruments designed to measure knowledge, cognitive function and selfcare. Although the authors sought to associate the concepts, no mixed methods questions
were posed. The study sample was limiting for purposes of this proposal: predominantly
male, relatively young, with some level of college education, drawn from a HF specialty
clinic.
Riegel et al. (2009) conducted a cross sectional mixed methods study on 29 HF
patients to determine their ability to detect shortness of breath and report it. They
compared two groups, younger (< 73 years) and older (≥ 73 years) to assess whether
aging impacted a patient’s ability to interpret her HF symptoms. A 6-minute walk test
was employed to stimulate shortness of breath using the Borg measure of perceived
exertion. The two groups were compared for accuracy of ratings and in depth interviews
were conducted to inform symptom interpretation ability. The data reflected a decreased
ability to detect and interpret shortness of breath supporting the authors’ theory of an agerelated decline in ability to sense physical symptoms.
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Summary
This chapter has presented the theoretical foundation for this research. The
philosophical underpinnings and essential constructs of the Self-Efficacy Theory have
been described. Pertinent literature was discussed as it relates to this study. Finally,
instruments that were developed using Self-Efficacy Theory were described.
Patients with HF face significant barriers in managing their prescribed regime at
multiple points on the health care continuum. To begin, HF guidelines are not employed
universally and patients’ medication records are often inaccurate. Furthermore nurses,
whose primary responsibility is education, are ill equipped to provide the necessary
instruction for HF patients when discharged from the hospital. Once home, patients
confront personal barriers including complex therapeutic regimes, inability to recognize
symptoms, declining self-care ability, and a lack of support systems.
Finally, this chapter summarized pertinent literature as it relates to the constructs of
this study. Quantitative issues related to self-medication and self-care practices of HF
patients were presented. This was followed by an overview of qualitative literature as it
sought to inform nursing on one component of a HF patient’s life. Limitations and
conclusions of the research cited were identified. The lack of existing literature on the
self-medication practices and self-efficacy of HF patients living independently at home
was concluded.
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Chapter 3
Design and Methodology
This chapter presents the philosophical underpinnings of mixed-methods research.
Quantitative and qualitative research designs and the methodologies of each are
described. The procedures for protection of human subjects, recruitment, quantitative and
qualitative data collection procedures and analyses of all data are presented. Threats to
validity and integrity are also described.
Methods
Design
The mixed methods design fulfills two purposes of research: elaboration and
development (St. Arnault & Fetters, 2011). Elaboration is the adaptation of data from one
source to clarify and elucidate data from another source. Development is the utilization of
the data from that source to create an instrument or to select methods of data analysis.
Within the mixed method design the inductive contextual approach is integrated with the
deductive generalizing approach (Morgan, 2007). The central premise of mixed methods
research is, “the use of quantitative and qualitative approaches, in combination, provides
a better understanding of research problems than either approach alone” (Creswell &
Plano Clark, 2007, p. 5). Mixed methods research, in its combination of methodologies,
increases the depth and breadth of resulting data and is more apt to discover knowledge
and explain results.
In 2009, the National Institute of Health hosted a summit on health disparities that
concluded that mixed methods research was ideal for addressing the complex issues of
inequities (as cited in St. Arnault & Fetters, 2011). HF, with its complicating presentation
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of symptoms and comorbid conditions, lends itself to this method of research with its’
worldview of pragmatism to explain both the qualitative and quantitative components of
the disease.
This study used a convergent parallel mixed methods design (Figure 2). It
involved collecting quantitative data on patients, > 50 years old, living with HF. This was
followed by an in depth qualitative component. The quantitative strand was meant to
validate and provide greater insight into the qualitative results (Creswell & Plano Clark,
2011). Following the completion of the quantitative interview, HF medication selfefficacy and/ or outcome expectation self-efficacy mean scores were calculated
independently. Patients were asked if they would be willing to participate in the
qualitative interview if they scored higher (≥ 4) and lower (≤ 3) in either measure to
discover the experience of following the prescribed regime. The results of these
qualitative interviews informed the researcher on the process of patients’ medication
adherence and self-efficacy related to their regime when living with HF.
A myriad of challenges are confronted when using this design. To begin, a
researcher must be knowledgeable in both the inductive and deductive methods of
research to honor the fundamental structure and underlying philosophy of each method
while utilizing an integrative framework (Creswell & Plano Clark, 2011). She must also
be aware of the framework that guides mixed methods research and construct a study that
integrates the data using the back and forth blending of the singular and multiple views of
reality (Morgan, 2007). The researcher proposing this study has studied the different
elements constructing the mixed methods design and has excellent expert resources to
guide the study.
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Furthermore, Ivankova, Creswell, and Stick (2006) emphasize the mixed method
design demands clarification on many levels, including priority of weight given to
quantitative versus qualitative strands, sampling issues and timing for the integration of
the data. For this study, the quantitative and qualitative components were given equal
weight due to the lack of research in both areas. At the completion of the quantitative
interview, participants who scored high or low in HF medication self-efficacy were asked
if they would be interested in continuing the interview. Patients were asked to describe in
as much detail as possible their thoughts and feelings related to living with the
medication regime. This ensured an adequate sample of patients to complete the second
component of the study.
Instruments
ActualMeds™
ActualMeds™ is a medication use instrument that was developed from The
Personal Education Program-Next Generation (PEP-NG), an interactive computer-based
educational intervention (Neafsey et al., 2011). The PEP-NG has been shown to be
effective in increasing knowledge and self-efficacy related to the patient’s medication
regime and decrease adverse self-medication practices in older adults with hypertension
(Lin et al., 2009; Neafsey, Strickler, Shellman, & Chartier, 2002; Neafsey et al., 2008,
Neafsey et al., 2011). The University of Connecticut granted an exclusive license for the
PEP-NG to AdhereTx Corp (now Actual Meds Corp) for commercial development as a
data capture and analysis instrument. Key elements of the PEP-NG that were
commercialized as a part of the ActualMeds™ system include a structured patient
interview and risk rules / scoring that were re-developed for secure, HIPAA-compliant
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commercial delivery in a variety of healthcare settings. Additional functional capabilities
were developed by ActualMeds™ to support integrated team-based care, provider-based
comprehensive medication review / Medication Therapy Management (MTM), and
automated medication reconciliation between external data sources including electronic
health records (EHR), medical and pharmacy claims and patient-reported medications. A
rules engine analyzes patient data (including what, when and how often self-reported Rx)
and lifestyle behavior (including tobacco use, alcohol consumption, and hours of sleep) to
calculate risks (High ≥ 25; Medium ≥10; Low <10). The rules engine delivers a highly
targeted medication interaction list to stratify patient-reported behaviors with the highest
risk scores. A total risk score is generated which is the sum of all of the risks identified.
Interactions/lifestyle behaviors generating risk scores are derived from a
Lexicomp database (Wolters-Kluwer) rule set (with risks scored on a 1-5 point scale,
where a score of 5 is a high risk that is likely to cause an adverse outcome, thus the
interaction/ lifestyle behavior should be avoided). Additional rules are derived from
published guidelines from the Beers Criteria for Potentially Inappropriate Medication Use
in Older adults (American Geriatrics Society, 2012), American Diabetes Association,
American Heart Association, Word Health Organization, Centers for Disease Control,
National Heart, Lung and Blood Institute, US Food and Drug Administration, and US
Department of Agriculture. Interactions/behaviors not already in the Lexicomp database
or in national guidelines are also derived from the peer-reviewed literature and subjected
to a modified Delphi review method using a 5-member expert panel to review the
published evidence and select those interactions/behaviors having the greatest likelihood
of an adverse outcome. The expert panel members have experience and research
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expertise concerning clinical drug-interactions and self-medication behaviors. The Delphi
panel uses the same Lexicomp 5-point scale to assign an importance weight for each
behavior. The risk score for each behavior is the mean of the expert panel ratings. Those
behaviors with a mean score of 1 or higher are retained for the rules engine.
The HF Medication Self-Efficacy Instrument
The HF Medication Self-Efficacy Instrument (Knecht, 2012) was developed
based on previously validated instruments that measure self-efficacy related to
medication adherence in different populations: older women with osteoporosis (Resnick
et al., 2003) and persons living with HIV (Erlen et al., 2010). Patients were given a set of
5 response options, with 1 being not at all confident and 5 being totally confident. Lower
scores were associated with negative feelings related to confidence and higher scores
were associated with increased confidence. This 15-item instrument (Figure 3) was pilot
tested on patients aged 60 and over taking cardiac medications recruited from senior
centers throughout central CT; 6 participants for each item, 93 participants total.
Principle component analysis was performed using SPSS (version 19) on the 15
items. Using Kaiser’s criterion (Eigenvalues > 1) and examination of the Scree Plot, 3
components were derived which accounted for 82.85% of the total variance. Using an
oblique rotation with the Oblimin and Kaiser normalization procedure, the pattern matrix
resulted as represented in Table 3. Assessing the pattern matrix, 6 items with the highest
loadings formed Component 1, Outcome Expectations. The Varimax rotation was
employed to discern the proper order of the components in accounting for the variance
(Gable & Wolf, 1993). The Varimax reversed the order of components 2 and 3.
Questions 1, 2, 3, 5, and 8 were reflected in Component 2, Illness. Finally, items 7, 6, 4,
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and 9 comprised the third component, Disruption.
Cronbach’s alpha for the data from Component 1, Outcome Expectations, was .98,
with a mean inter-item correlation of .89. The corrected item-total correlation was >.90
and Cronbach’s alpha if item deleted remained >.97 for all items within the factor, hence
no items were deleted.
Component 2, named Illness, resulted in an alpha reliability form the data of .89
and a mean inter-item correlation of .64. Again, no items were deleted because corrected
item-total correlation and Cronbach’s alpha if item deleted were all within a desirable
range.
Finally, the third component named Disruption, reported a Cronbach’s alpha for the
data of .91 and a mean inter-item correlation of .72. Since the weakest item, question 9
Reminders, if omitted, resulted in an alpha reliability of .91 - the same as with the item;
the question was deemed relevant and kept within the aggregate. The empirically derived
components, represented in Table 3, matched that of the outcome expectations for
medications from the literature. However, whereas the researcher thought that the first 7
items were a single component related to self-efficacy in knowledge related to ability to
take medications, two factors were derived from the analysis. Component 2 and
component 3 were recognized are not distinct constructs because they correlated
(0.51)(Table 4). Accordingly, Component 3 constructs were merged into Component 2,
Illness.
The HF Medication Self-Efficacy Instrument was developed and validated to
measure two dimensions of medication adherence. With relevance toward patients with
HF, the constructs that were defined included perceived ability in taking prescription
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medication (Self-Efficacy) and perception of the medications’ value (Outcome
Expectations). Self-efficacy expectations were measured by asking a series of questions
to discern the participant’s confidence in his/her ability to self-medicate accurately and
safely and outcome expectations were measured by asking a series of questions to discern
the participant’s confidence in his/her medications improving his/her quality of life.
Ethical Considerations
Approval of the Institutional Review Board from Middlesex Hospital was sought
and obtained prior to initiation of the study. Patients were given an information sheet
explaining the research study. It was explained to patients that participation was
voluntary and at any time they were able to withdraw from the study. Completion of the
phone interview was deemed consent.
Sample
Middlesex Hospital Home Care reported enrolling over 50 HF patients each
quarter of a year. The population served by the home health agency was ethnically
diverse with varied levels of education and socioeconomic status. Inclusion criteria for
this study were: 1) diagnosed with HF, 2) over the age of 50, 3) taking prescribed
medications for HF, 4) independent physical and cognitive functioning, and 5) English
speaking. The telehealth nurse manager reviewed the patient records to exclude terminal
Stage IV HF patients who had been referred to hospice. Patients with Stage II, Stage III,
and IV were referred to the primary nurse caring for the patient. Independent functioning
was assessed by the home care nurse, based on the patient’s ability to perform activities
of daily living and complete self-care required for a patient living independently with HF.
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The primary nurses recruited the patients to participate in the study and provided contact
information for the researcher.
Procedure
Quantitative and Qualitative Strand
Patients with HF, who had been engaged in home health were given a poster by the
visiting nurse to inform them of the research study, along with an information sheet and the
self-efficacy instrument. If the patient was not actively participating in home health care,
the documents were mailed to the patients from the Middlesex Home Health Agency. The
primary researcher followed up with a phone call to discuss the study and answer questions.
Following a description of the study, patients who wished to participate spoke to the
primary researcher on the telephone. The nurse researcher (graduate nursing research
student): 1) collected demographic information including: age, sex, race, last year of
completed education, 2) completed the ActualMeds™ structured interview (that queries
recent symptoms, lifestyle behaviors, prescription medications, self-medication and OTC
behaviors), 3) compared patient reported medication behavior to a paper medication
adherence record obtained electronically form the primary care nurse (including all Rx and
OTC medications the patient reported taking in the previous month), and 4) obtained blood
pressure (BP) and weight measurements via biometric devices or self-reported (Pickering et
al., 2010).
ActualMeds™ uses a virtual private network. Data collected, including demographic
and mediation use survey, were downloaded onto the nurse researcher’s hard drive and
then to the research database via a secure server. Private information including patient’s

PATIENTS AND HEART FAILURE MEDICATIONS

39	
  	
  

name was not collected. The principle investigator (PI) and the nurse researcher were the
only individuals with access to the raw data.
After completion of the quantitative strand, participants who scored higher (≥4 confident) and lower (≤3- not as confident) in self-efficacy were asked to participate in the
qualitative component of the study. This strand was comprised of an audiotaped interview in
which the participant was asked to answer two open-ended questions. The first question was
intended to uncover the patient’s experience living with HF and is aligned with qualitative
method of inquiry. The second is congruent with self-efficacy theory.
1.) Please describe your experience of living with HF since your diagnosis. Please
describe for me in as much detail as possible a day that you feel represents what it means
to live with your diagnosis.
2.) Can you tell me about your level of confidence related to following your prescribed
regime? Probing questions were asked when the researcher wanted the patient to
elaborate on a scenario the participant recounted.
Threats to Quantitative Internal Validity
Rigor was examined and potential threats were identified. History was addressed
during the study. Any news related to HF was noted as a possible threat to validity.
Mortality was a potential threat and could have occurred with this population; it did not.
Patients might have had different levels of understanding of their illness, based on their
own level of education, years since diagnosis, and their family history. Patients recruited
were nearing the end of home health service. Due to the time elapsed in connecting with
patients, they had different levels of acuity. Selection might have affected internal
validity. Those patients agreeing to participate might have been more highly informed.
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The researcher strived to recruit an ethnically, economically and educationally diverse
population. All instruments used were previously validated (Neafsey et al., 2011; Knecht,
2012).
Threats to Quantitative External Validity
There may have been some influence rendered by the quantitative interview to
change the patient’s perception of his/ her health status; however, the value of the design
and the data collected outweighed the threat. Only patients that were enrolled in the HF
home health program had the ability to participate in the study. These patients may not
have been representative of the general population living with HF. For the purpose of this
study, one location was used; however, future studies will extend to other settings.
Distractions were minimal because data collection took place in the privacy of the
patient’s home and the nurse researcher was on the phone. If the patient were busy, the
nurse researcher offered to call back at a more convenient time and a date and time was
planned.
Threats to Integrity
The definition of the concepts and the theoretical foundation provided the
qualitative researcher with the framework to guide the study and ensure the reliability of
data generated. Further protection was assured through the careful application of
Krippendorff’s method of content analysis for qualitative study (Krippendorff, 2004).
The researcher was committed to reflexivity; that is, required to set aside any prior
experience or bias with the population in order to enter the qualitative data collection
phase and continue to self-reflect throughout the data collection and analysis (Beck &
Gable, 2012).
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Peer debriefing was employed to ensure reliability of results. The nurse researcher
discussed the process with peers who are expert in qualitative methods. Member
checking was completed in order to provide verification of the preliminary results (Beck
& Gable, 2012). An audit trail was maintained in order to provide a reference for future
researchers.
Quantitative Data Analysis
Coded data were downloaded via the secure, HIPAA-compliant ActualMeds™
database and entered into an SPSS (version 19) data file. Descriptive analyses were
conducted on all variables organized by gender, race and age. Frequency distributions of
the HF medication self-efficacy, ActualMeds™ risk score, and BP were analyzed.
Correlation statistical analyses were conducted between SE scores and ActualMeds™
risk scores.
In a post hoc analysis, anticholinergic burden was measured. Anticholinergic
burden has been identified as a potential risk of morbidity and mortality in older adults
(Cai, Campbell, Khan, Callahan, & Boustani, 2013; Campbell et al., 2009; Carnahan,
Lund, Perry, Pollock, & Culp, 2006; Rudolph, Salow, Angelini, & McGlinchey, 2008).
The anticholinergic cognitive burden (ACB) scale (Cai, Campbell, Khan, Callahan &
Boustani, 2012) further details the level of anticholinergic activity and the level of
associated risk for the medications identified. Three panel members including a
geriatrician and two geriatric pharmacists reviewed the 500 most prescribed medications
and medical literature related to their anticholinergic adverse effects (Cai et al., 2012).
They ranked the medications according to associated anticholinergic burden identified: 0;
limited or none; 1, moderate; 2, strong; and 3, very strong.
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Qualitative Data Analysis
Audiotaped sessions recorded during the qualitative interviews were transcribed
verbatim by the researcher. Transcripts were analyzed using Krippendorff’s (2004)
method of qualitative content analysis to derive themes. Krippendorff (2004) advocates
“each body of text is unique, affords multiple interpretations, and needs to be treated
accordingly” (p. 87). According to Krippendorff, qualitative content analysis enables the
researcher to select text that is relevant, interpreting that text and returning to earlier
interpretations based on later readings and interpretations. The researcher “settles for
nothing less than interpretations that do justice to a whole body of texts” (p. 88).
Interpretations were supported by quotes of participants (Krippendorff, 2004). The quotes
constructed parallels and elaborated on metaphors (Krippendorff, 2004). Triangulation
further enhanced the results (Krippendorff, 2004). A meticulous audit trail was recorded
to afford readers the process of conclusions drawn by the researcher. Finally, the
researcher continued to engage with methodologic peer experts throughout the process to
insure that alternative perspectives are considered (Krippendorff, 2004).
Mixed Methods Data Analysis
According to Creswell and Plano Clark (2011), when employing the convergent
parallel design, data from the quantitative and qualitative strand are analyzed
independently using procedures suited for the methodologic approaches, as described
previously. Data were collected and analyzed as patients entered the study. Following
consent, the quantitative interviews were conducted. Qualitative interviews were
conducted on a purposeful sample of patients who scored high and low in HF medication
self-efficacy. As the researcher examined the quantitative scores and the qualitative
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transcripts, the researcher identified the dimensions that were compared and defined
those constructs. Side-by-side comparison was conducted during the merging process.
Quotes from the qualitative interviews were used to further enrich the quantitative results.
The comparisons were articulated and the researcher interpreted the combined results.
Ultimately, the results were compared to the research questions.
Summary
This chapter presented the research design, sample, protection of human subject
procedure, and instruments used in the study. The methodology and study procedure were
reported. Potential threats to integrity and limitations were described. Data analysis
procedures were illustrated for the quantitative, qualitative and mixed-methods
components.
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Chapter 4
Results
This chapter will describe the sample and elements of the quantitative, qualitative,
and mixed-methods results from the study. Relevant findings will be presented as they
relate to the research questions. Data, with pertinent statistics, and its significance to
nursing will be described.
Purpose
The primary aim of this study was twofold: 1) to describe HF patients’ overall
self-medication and life-style practices and determine their self-efficacy as it relates to
these practices and 2) to describe the themes derived from qualitative interviews of
patients who scored high and low in HF medication self-efficacy. This study used scores
derived from the ActualMeds™ instrument that queries recent symptoms, lifestyle
behaviors, prescription medications and OTC behaviors to stratify risk of medication
interaction. The study also analyzed self-efficacy scores of medication use and outcome
expectations. The data presented within will answer the following questions.
Quantitative Research Questions
What are the self-medication practices of patients living with HF?
What are the medication self-efficacy (SE) scores of patients following his/her HF
medication regime?
What is the relationship between self-efficacy scores and the number of medications or
risk score of HF patients in this study?
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Data Collection
If the patient were deemed eligible, the primary nurse would give the patient the
research information sheet, describe the study and pose the question of participation. If
the patient was amenable to participation, the medication self-efficacy instrument was
given to the patient to consider until the nurse researcher contacted the patient.
Fifty patients were referred to the nurse researcher and contacted by telephone. If
patients answered the telephone, they were asked if it were a convenient time to discuss
their medications. If they were not home or did not answer, a message was left
introducing the researcher, briefly describing the interview procedure, providing the
researcher’s phone number and informing them a return phone call was welcome or the
researcher would try again. Four patients answered during this time stating, “I did not
recognize the number,” and proceeded to complete the interview process. Due to lack of
response to telephone calls, eight patients were dropped after three attempts to contact.
One declined to participate stating, “ I don’t remember the nurse asking… I am not
comfortable.” In all, 41 patients participated in the study. Data collection was at a single
point in time. Phone interviews ranged in duration from 21 minutes to 49 minutes.
The participants were primarily Caucasian (98%) females (58%) ranging in age
from 52-94 (see Table 5). African-Americans represented the other 2%. Fifteen percent
reported less than 12 years of education, while 54% reported high school as their terminal
degree. The mean age was 81 (SD ± 8) years. The participants were English speaking,
living independently at home.
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Part I: Quantitative Results
The comorbid conditions reported by patients are represented in table 6. A
majority of patients reported a history of high blood pressure (N=23, 56%). Only 11
patients reported having diabetes. Two patients reported their HF began as a result of a
virus. One patient reported he had been an alcoholic. One patient had lupus. One fourth
(N=9) of the population reported having chronic obstructive pulmonary disease, asthma,
or emphysema. Thirty percent of patients self-reported their health as good, 14% average,
22% fair, and 17% poor. Thirty-three percent reported some combination of anxiety and
depression (Table 5).
Patients reported a mean number of 12.6 (SD ± 5) medications (range 6-25), 38 of 41
patients (93%) with multiple dose times and multiple prescribers. OTCs accounted for
29% of medications. All patients reported taking five or more prescription medications.
Most patients reported medication adherence (95%). Only two patients admitted that they
knew they missed doses due to failing to remember to take them.
A total of 16 medications were prescribed for HF in the participants interviewed. The
most commonly prescribed categories of medications are represented in Table 7. Antihypertensive medications included metoprolol, prescribed to 13 patients (32%), Coreg
(carvedilol) 12 patients, lisinopril 8 patients, followed by diltiazem 5 patients, Diovan
(valsartan) 4 patients, Norvasc (amlodipine) 2 patients, and Corgard (nadolol) 1 patient.
The most common categories of anti-hypertensive medications were beta blockers (61%),
ACEIs (20%), calcium channel blockers (17%) and angiotensin receptor blockers (ARB)
(10%). Loop diuretics were prescribed to 26 patients (61.9%) with Lasix (furosemide)
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most common; Bumex (bumetanide) was prescribed to one patient. Aspirin was
prescribed to 16 patients. Anticoagulation therapy was prescribed to 14 patients:
Coumadin (warfarin) 11 patients, Xarelto (rivaroxaban) 3 patients.
Despite the extensive number of medications that patients were prescribed, only 46%
met three recommended concurrent medications for HF per prescription guidelines: ACEI
or ARB, beta-blocker, and loop diuretic (Yancy et al., 2013). Digoxin is the fourth
recommended medication for HF but remains highly controversial in this aged population
due to its potential to cause dysrhythmias, increase myocardial oxygen consumption
(Kaiser Permanente, 2013), and it is on the Beers list (AGS, 2012) (see below).
Therefore, the 46% who were prescribed the ACEI/ ARB, beta-blocker, and loop diuretic
concurrently will be reported as met current (2013) guidelines. (Of the patients
interviewed, 17% took digoxin as well as the three aforementioned medications for HF in
the 2013 guidelines.)
Discrepancies in the medication regime when compared with the EHR received from
the home care agency were identified for 26 patients (51%). Sixteen (39%) of these
discrepancies were due to recovery from an acute exacerbation of respiratory failure or
recovery from a musculoskeletal injury/ surgery and the indicated medications were no
longer needed. Examples included stool softeners, pain medications and treatment for
acute respiratory failure. In addition, 13 patients (34%) reported taking medications
(range 1-9) not listed on the EHR. These included changes made the HF regime since
discharge and other OTCs. One patient had misunderstood his discharge instructions and
simply stopped taking his newly prescribed HF medications including his diuretic,
nitrate, and ARB after completion of the month’s regime because there were no refills.

PATIENTS AND HEART FAILURE MEDICATIONS

48	
  	
  

The mean medication risk score calculated from the total medication profile by the
ActualMeds™ system was 63 (SD ± 50; range 17 to 276) (Table 8; Figure 4). There was
a strong positive correlation between the risk score and the number of medications (r =
.70, n = 41, p < .001) (Figure 5). The ActualMeds™ instrument generated a high-risk
total score (high ≥ 25; medium ≥10; low <10) for 86% of patients indicating the patient’s
regime had multiple, high-risk medications and/or drug-drug interactions. Ninety-five
percent had at least one “5” score indicating and urgent need for medication
reconciliation and review. Most of the high risks were related to medications that appear
on the Beers list of potentially harmful drugs (AGS, 2012) for the gerontologic
population. The Beers list was originally intended for use in the long-term care setting,
but it has been adapted to all environments (AGS, 2012). It is a consensus list with level
of evidence referenced citing medications deemed inappropriate in the elderly. The
results demonstrated 29 patients (71%) took at least 1 Beers medication; 51% had two or
more Beers medications (Table 9). Of those taking medications on the Beers list, 48%
had related symptoms. In particular, five patients (17%) reported they had fallen in the
last year. Other symptoms reported that were related to Beers medications included
unsteadiness, near fall, fatigue, dizziness, leg cramps, and constipation. Cognitive
changes may also present as a side effect in patients prescribed Beers medications with
anticholinergic side effects (see below).
Ninety-five percent of patients surveyed in this study reported medications with
anticholinergic side effects and risk of cognitive impairment (Table 10). Applying the
Anticholinergic Cognitive Burden (ACB) Scale (Cai, Campbell, Khan, Callahan &
Boustani, 2012) to the current results, 78% had at least a moderate anticholinergic burden
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(ACB) score (2 or more) and 54% had a high anticholinergic burden score (≥ 3, range 310). Of the 41 patients interviewed in this study, 28 reported they were prescribed the
loop diuretic furosemide that has an ACB score of 1 and is one of the medications
recommended for HF in the ACC guidelines. Another 12 patients reported the betablocker metoprolol, which also carries an ACB score of 1 and is one of the ACC
recommended medications for HF. Finally, 12 patients were prescribed warfarin for atrial
fibrillation. Patients prescribed these three medications for HF would carry an ACB
burden of 3 if they were taking nothing else. Six patients (15%) were prescribed this
combination. Patients were also prescribed other medications with anticholinergic side
effects including those with ACB scores of 3: Bentyl (dicyclomine), Ditropan
(oxybutynin), Paxil (paroxetine), and an ACB score of 2: Tegretol (carbamazepine),
Flexeril (cyclobenzaprine), and various opioid pain containing medications. A total of 14
other medications with ACB scores of 1 were prescribed to patients. Also, one of these
patients self-medicated with OTC diphenhydramine (ACB score = 3) and two patients
took other OTC antihistamines (cetirizine and loratadine) (ACB score = 2). Only one
patient was prescribed donepezil, the recommended treatment to allay the impairment
caused by the anticholinergic side effects.
Of the seven patients who reported anxiety as a symptom, three were untreated.
Four patients were treated with either a selective serotonin reuptake inhibitor (SSRI) (2
patients) or a benzodiazepine (2 patients); all medications on the Beers list. Of the 5 that
reported both anxiety and depression, all received treatment; all were treated with
medications from the Beers list (AGS, 2012).
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Outcome Expectation Scores
To determine if there were a relationship between demographic variables and the
patient’s outcome expectation self-efficacy (OESE) score, statistical tests of association
were conducted. Exploratory descriptive analyses were conducted on all variables to
assess normality of the distributions and to insure the basic assumptions of the statistical
tests were not violated.
The OESE score was generated from the average of all constructs measuring selfefficacy outcome expectations. This score reflected the patient’s confidence that his/ her
medications were improving his health. The outcome expectation scores were not
normally distributed, therefore a non-parametric correlation test was conducted to explore
the relationship between OESE scores and risk scores. There was a small negative
correlation between the two variable (r = -.27, n = 41, p < .095) (Figure 6). Because of
the evidence of non-normality, the Mann-Whitney test, a rank-based non-parametric
technique was conducted to compare the outcome expectation scores between males and
females. The test yielded a p-value that was not significant (p < .17). However, both the
mean and median outcome expectation score were somewhat lower for men than women
(male mean = 3.6, SD ± 1.3, female mean = 4.2, SD ± 85, male median = 3.8, female
median = 4.5). In addition, the outcome expectation scores were more variable in men
(male interquartile range = 2.4, female interquartile range = 1.7)
Age was normally distributed for the population sampled. The relationship
between age and outcome expectation score was investigated using the Pearson product –
moment correlation coefficient. Because outcome expectation scores were not normally
distributed, a nonparametric correlation was conducted. The test yielded no significant
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(p < .62) correlation between age and outcome expectation score in the sample measured;
however, on average, the outcome expectation score went down as the participant’s age
increased.
The ActualMeds™ risk scores, number of medications, education level and
systolic and diastolic blood pressure measurements were normally distributed. No
significant relationships were found between the outcome expectation score and the
ActualMeds™ risk score (p < .22), number of medications (p < .059), education level
(p < .80), systolic blood pressure (p < .59) or diastolic blood pressure (p < .22).
Medication Regime Self-Efficacy
The average medication self-efficacy (MSE) scores of a patient measured the
patient’s confidence that he or she were managing the regime correctly (5- totally
confident and 1- not at all confident). This sample was highly confident that they were
following their regime correctly. Of the 41 patients, 34 (83%) were very confident (MSE
= 4) to totally confident (MSE = 5) that they were following their regime correctly.
Eleven patients (17%) scored ≤ 3 on the MSE.
Part II: Qualitative Results
The data presented will answer the proposed research question: what are the
themes described by patients living with HF who score high and low in HF medication
regime self-efficacy and outcome expectations on the HF Medication Self-Efficacy
Instrument? Patients who had a mean score higher (≥ 4) or lower (≤ 3) in medication selfefficacy and/ or outcome expectation self-efficacy were asked if they were willing to
answer an open-ended question related to living with their prescribed regime. The
interviews were audiotaped and transcribed verbatim. A total of 21 patients were
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interviewed to reach saturation: 10 patients with lower self-efficacy scores and 11 with
higher self-efficacy scores (Polit &Beck, 2012). Throughout the data three themes were
revealed: social support, attitudes and beliefs, and formulating coping strategies.
Through listening to the words of the patients, a story emerged that related either
a positive or negative transition to management of the regime (Meleis et al., 2000). Social
support as well as the patient’s own philosophy of life either promote a positive or
negative transition. Patients often described symptoms within the context of a situation.
Patients with higher self-efficacy related a sense of confidence in their ability to manage
daily life; however, patients with lower self-efficacy recounted feelings of
discouragement. Patients with low medication regime and outcome expectation selfefficacy presented a narrative of being lost, alone, often overwhelmed due to the
complexity of routine care. Throughout the interviews, these factors and the themes
derived became clearly articulated in the words of patients.
Overall patients remained highly confident that they were following their regime
correctly. Only a few patients did not report confidence in their regime. This cohort of
patients chronicled a life with little hope and loneliness.
Social Support
Social support included family, friends, neighbors, and peers. Family included
spouses, partners, sons and daughters, nephews and grandchildren. Patients with high
self-efficacy scores described support systems and the comfort they provided. Patients
who did live alone, but who felt they could depend on a family member nearby related
more positive self-efficacy scores.
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A young woman with a left ventricular assist device (LVAD) awaiting transplant
had succumbed to HF as a result of a virus. She had never taken a medication prior to this
event; hence she explained she was not totally confident that she took them correctly
when she has a busy day or her normal routine was interrupted; otherwise she was totally
confident in her medications’ ability to improve her health. She ascribed her positive
feelings to the support she received from her partner. She stated, “I live with my domestic
partner, I couldn’t do it without her.”
Social networks were carefully constructed by individuals to enhance their ability
to continue to function successfully within the confines of their limitations.
“We have a good support system through the church. Thursday we are going
to Yale… to see if a pacemaker or defibrillator might help me. A fellow from
the church and his wife are going to drive us….”
Patients relied on different individuals for different assistance. One patient stated,
“We have fantastic neighbors…no matter how little the snow, he or his wife come over
and clear our driveway. We call them our snow angels.”
Patients described the adjustments made to their daily routines and goals set to
maintain social connections. “I know on Monday mornings I have to take it easy, because
I like to go to Tai chi. If I start cleaning up, I will get too tired. I go mostly to see my
friends.” Another grandmother stayed home on Fridays, looking forward to Saturdays, “I
like to get out with a goal… because I will see my grandchildren in their soccer games.”
One woman who lived with her daughter and grandchildren stated she took care
of herself, meaning personal care, but she didn’t have to worry about cooking and
cleaning. Her daughter accompanied her to appointments and helped her with her
medications. If she wanted something, there was always someone to get it for her.
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Patients stated it was critical to have someone help with the regime. They
reflected on those who helped them and related a sense of bewilderment at the thought of
having no one to do so. It is clear that social support has improved the self-efficacy and
facilitated the transition of the patients interviewed in this study.
Patients with lower self-efficacy often lived alone and their story related a sense
of discouragement. One gentleman stated,“I live alone, my children don’t live near me. I
use my medicine box, but I still find that I miss some medications. I don’t remember, the
days run together...” Another widower stated, “I am home most of the time, I don’t go
anywhere… I am legally blind. I cannot read print.”
Finally, a recovering alcoholic who had been sober for 17 years and lived alone
without family support apologized when he self-rated his health as poor. “It is not very
encouraging, I am sorry.” He was fairly confident he took them correctly, most were
taken early in the morning; but when asked if he felt they were helping he stated, “I am
not sure…I’ll be honest with you I am not sure how much good they are…I really don’t
know. I am overwhelmed really, I am taking so much stuff”.
Attitudes and Beliefs
The patient’s perspective of life was influenced by his own attitudes toward
spirituality, life’s purpose, and current quality of life. Patients offered a myriad of
thoughts and feelings encountered within the framework of transitioning to their altered
daily lives. Attitudes and beliefs, as well as personal characteristics played a role in the
adaptation of patients to living with HF. Confronted with unfamiliar situations, patients
drew on inner strength and personal beliefs to successfully live with HF. Patients with
high self-efficacy related that one could not expect to feel well every day.
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Spirituality was embodied differently to different patients. One patient related,“I
believe that medication helps and God gave all of you the knowledge to do what you
do…” Another patient professed his faith and spirituality more literally, “See I am a very
Christian person. I believe I am going to be ok because my God said it. He said he would
take care of me and I am a strong believer in that.”
Patients with high self-efficacy outcome expectations believed that their
medications were of benefit to them. They believed that they helped them feel better and
improved their quality of life. Patients described positive attitudes and beliefs.
One woman stated, “I have a very good attitude toward the whole thing. I think you have
to think positively, not dwell on what you think might happen.”
Another gentleman stated,“ I like to think positively about the future.” Finally, a patient
related, “I don’t let anything stress me out, I can’t have that in my life.”
Patients with low self-efficacy related feelings of defeat or despair. One man
stated, “It is getting tiresome. I am seeing a psychiatrist once a week. I am 70…
It is not very encouraging, I am sorry.” Patients often were ambivalent about their daily
routines due to fatigue resulting from daily care. A man stated, “I feel beat most of the
time.”
Formulating Coping Strategies
Patients with high overall self-efficacy described behaviors used to adhere to their
regime. Patients with a longer history of required medications described the process of
medication adherence as a matter of routine. One patient was diagnosed with Lupus at a
young age; she was highly educated and had been on medications her whole life. When
she developed HF, medications were already part of her regime. She stated, “I have been
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taking them for such a long time. I know what I am doing. We are a medical family. My
son is a doctor. My daughter is a nurse….”
Patients with high medication regime self-efficacy scores were totally confident.
One patient simply stated:
Oh I am sure I take them correctly. They told me exactly how to take them
when I was in the hospital and that is what I do. If I am taking them wrong,
well they were wrong then”
As for daily routines, patients recounted their belief in the importance of the
medications and their own adherence regime. “The most important are in the
morning…. And I just do it.” Others related careful discipline to routine. This woman
worked with her daughter with whom she lived,
“I have a two-week medicine box. I live next to my daughter and we do my
box together. We fill it on the second week, we keep track of all of the
substitutions, and we write them down. She fills it up for me, like today they
cut something in half, so she came right in and took the second one out of my
box.”
Collaboration was imperative. Another patient stated, “I live with my husband
and he has his medications also. We each use a medicine box…we do them Saturday
morning for the entire week. A woman whose husband had died stated, “I live with my
daughter. My husband died last August. It is too many for a pillbox. I use a chart. I am
very confident. I take them correctly.”
They were masters at adjusting activities, collaborating with others, and using
creative solutions. Planning had become an integral part in their day-to-day success.
Patients related many creative solutions to enhance adherence to self-monitoring and selfregulating behaviors necessary to maintain equilibrium. One elderly patient stated, “I
have bought some glasses that are magnifying glasses that help. I have macular
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degeneration…. I am contemplating hiring the girl next door to come up and check my
medicines.”
A retired army officer related a story of the systematic approach required to
successfully maintain a level of wellness, which included daily exercise. Patients related
the careful details of charts, pill-boxes, and alarms used to remember medications along
with anyone who would work with them to insure the accuracy of the procedure. Patients
actively worked to maintain equilibrium and prevent decompensation in order to maintain
some level of normalcy in their life. They related the self-care daily weight requirement
and the prescribed Lasix if they were retaining water.
Maintaining balance also entailed careful planning. If they knew they were going
out in the afternoon, patients rested in the morning. They kept daily diaries of activities,
rest periods and symptoms, and the changes in daily life and treatment regimes made as a
result. They recognized that they were not as strong as they once had been, but
understood the changes required to accomplish their goals. A few patients related that
they needed to “get off of the chair”. It was hard to initiate the exercise routine every day,
due to fatigue; however, once started they would feel better the whole day. “I walk ½
hour every day, briskly for me” with a chuckle. One patient stated he knew when he had
over done it,
Sometimes when I go to the grocery store, I buy too much and the bags are too
heavy. I pick up one of the bags and say ‘whoa these things are too heavy’ …I
get a little pain, so I put them down and rest until I am back to normal. Then I
remember for the next time.
Also critical to maintaining equilibrium is balancing the regime and the fear of the
onset of symptoms. Another retired army officer stated he knew how to take care of
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himself. He cooked for himself but confessed he wasn’t a very good housecleaner;
cleaning required more energy, it made him too tired. He was totally confident he
followed his regime correctly; however scored only 2.5 on outcome expectations. “ I am
totally confident that I take them correctly, that is no problem at all.” He was a widower,
and lived alone. He stated, “I think about taking them every day, but I know people are
trying to help so….I don’t seem to be getting any worse.” He confided that the regime
was restrictive, “I am getting to be a homebody because of the medicine.” Sadly,
avoidance of activities was described by patients with low outcome expectation selfefficacy in an attempt to allay the onset of symptoms.
Patients with high outcome expectation felt better as a result of their medications.
One gentleman stated, “Oh they have definitely improved my health. My heart rate would
have been 130…not too good.” Positive feelings related to the illness ascribed a
transition to acceptance of the required changes in lifestyle.
Ultimately, the themes described by patients living with HF seemed to parallel
Erikson’s final stage of development, Integrity vs. Despair (Erikson, 1997). Integrity is
demonstrated by individuals who are self-assured and find order and meaning in their
world. Despair is marked by persons who fear death and have lost independence and
significant others. For the patients in this study who have been living with HF for some
time, these descriptives seem to uncover the essence of the patients’ experience.
Part III: Mixed Methods Results
Most patients interviewed in this study described both positive and negative
feelings; however, those with positive self-efficacy reported a greater sense of control
over variables in their lives. In the analysis of qualitative data, themes derived aligned
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with Erikson’s final stage of development, Integrity vs. Despair. In those patients whose
descriptions of daily life illustrated integrity, obstacles were challenges to overcome, as
opposed to those with lower self-efficacy whose stories illustrated despair; barriers
encountered in daily life were described as too great to overcome. This section will
answer the research question:
To what extent do the quantitative scores of patients living with HF who scored higher
and lower in self-efficacy inform the themes derived from qualitative interviews?
The quantitative and qualitative data were analyzed bidirectionally in adherence with the
methodological philosophy of mixed-methods research.
Following analysis of risk scores generated from the ActualMeds™ rules’ engine
derived from the calculated risk of behaviors and medication interactions, self-efficacy
scores, and the derived themes, all data were analyzed side by side. There was a moderate
negative correlation (r = -.32) between the OESE and the number of medications patients
reported. Although not statistically significant, patients with higher OESE tended to be
prescribed fewer medications; and would risk fewer interactions. There was a strong
positive correlation between number of medications and risk score (r = .70, p < .001)
(Figure 1). For example, a patient with a calculated risk score of 17 reported the fewest
medications (5). There was a small negative correlation between OESE and risk score (r
= -.27). Although not statistically significant, patients with lower risk scores tended to be
more confident that their medications would improve how they feel and conversely,
patients with higher risk scores tended to have less confidence in their medications ability
to improve how they feel (Figure 2). Patients with higher self-efficacy scores described
support systems, positive attitudes and confidence in their ability to manage their regime.
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Higher risk scores were generated when patients described behaviors that added to
overall risk or were prescribed medications with potential interactions, such as
medications published on the Beers’ list. Patients with lower self-efficacy scores
described themes of being alone and often overwhelmed with daily life. These data reveal
the complexity of daily life and the evolving self-identified cognitive changes of this
aging population.
Finally, despite patient reporting of high confidence, the interview data reveal that
a myriad of errors and omissions occur. Patients living with HF warrant extended
interventions to assist in daily care. Description of the mixed-methods results will
transpire within the constructs of Integrity vs. Despair (Erikson, 1997).
Integrity
Patients with high medication regime self-efficacy and outcome expectation selfefficacy scores present a description of understanding of their prescribed regime. They
maintain a positive outlook and are comfortable functioning within a role of
interdependency. Spirituality is woven throughout the stories imparted by patients who
maintain integrity. A married patient on the fewest number of prescription medications
(7) but self-supplemented with 10 OTC medications, with a moderate risk score of 65
stated, “I think that is enough!” and the patient chuckled, not overwhelmed in the least
by her regime.
Relationships with children and grandchildren were also important, both for love
and support. One woman reported her level of wellness as fair, had a moderate risk score
of 51, and an anticholinergic cognitive burden score (ACB) of 3, but reported high selfefficacy in both constructs. She lived with her daughter and felt strongly that you needed
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to maintain a positive attitude. She said it was helpful that her daughter checked her
regime regularly to ensure she was on track. She had some ambivalence related to her
confidence, but ultimately stated, “In the last year we have made an awful lot of changes,
so I am not always sure that they have made me feel better… but I know they are helping
me.”
When patients maintain some decision-making authority, they have choices.
Patients recognized they still had a mission. A gentleman, 80 years old who had his
bladder removed and could not explain why, continued to feel a sense of contribution
despite his poor health rating. He lived with his daughter, a single mother with two young
sons. On 13 medications with a high-risk score of 89 and an ACB score of 5, he stated, “I
forget a lot, I am a little woosie…” but his living with them enabled his daughter to go to
work and study to be a nurse; hence he felt he was contributing. His blood pressure on the
day of the interview was very high; again the primary care provider was notified and
follow up was completed.
Despair
The incidence of depression in cardiac disease is well documented (Dobbels et al.,
2002; Freedland et al., 2003; Rumsfeld & Ho, 2005; Yu, Lee, Kwong, Thompson, &
Woo, 2008). Patients confided frustration and grief at the loss of prior level of
functioning. In a study on patients living with HF (Ryan & Farrelly, 2009) use the
analogy of an “illness-imposed incarceration (p.227).”
A recovering alcoholic with a high-risk score of 95 and an ACB score of 4 was on
multiple Beers medications as he recovered from a broken hip. Further complicating his
risk, he stated, “I smoke those electronic cigarettes … whatever the hell they are…a
couple times a day. I don’t go crazy with it.” He continued to reveal that he was orphaned
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at birth without any family; he stated with a sigh, “I’ll be honest with you, I am not sure
how much good they are doing… I really don’t know. I am taking so much crap.” He
finished his interview with, “it is getting tiresome. I am seeing a psychiatrist once a
week. I am 70….”
A woman with a moderate risk score of 52 on 11 medications (ACB = 4; 2 Beers
medications) stated, “Sometimes I wish they weren’t working so well. I get so tired.” A
patient who had recently fallen stated, “I take a lot of medications and I don’t feel any
better. You never dream that you will take so many…. I don’t see how they can all help."
Unfortunately, at times the confidence was unwarranted. Stress, anxiety, and
inadequate knowledge related to HF were also factors in management. In fact, patients
were making medication decision errors and failing to take all of their medications as
prescribed. A gentleman with a medication SE score of 5, who had been diagnosed within
the last year, stated that he was no longer taking his Lasix, “I had been taking them, but I
ran out of the pills and it just says no refill of the bottle… I thought that it meant I did not
have to take it anymore….” An ActualMedsTM action plan was created and the PCP was
notified with follow-up the next day. Patients confessed that they did not weigh
themselves daily because they didn’t have a scale. When they had been under the care of
the home health agency, it had been provided. “I took my weight every day when the
machine was here… but I haven’t taken it lately.”
Patients could ascribe to being totally confident, but in fact used no medicine box
or chart, and described poor regime practices. A patient who scored a five on medication
regime SE confided, “I am not as regular on the hydralazine… it says I should take 3
tablets a day.	
  Honestly I don’t take three tablets every day. On most days I take 2 tablets
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a day… I don’t remember it.” Another patient stated, “I do it myself… I just remember…
I have them all lined up… what I take every day.” Prescribed 12 medications and
caregiver to his wife in a wheelchair, this patient related multiple medication regime
errors and his primary care provider was notified and an action plan was created.
Finally, Patients would describe rationales for medications that they realized were
not part of their prescribed regime. A patient who had difficulty sleeping took a sleeping
pill, “I know you are not supposed to be on one, I don’t have to take more and more of it,
I have been on only one.” An older woman related a story of progressive disinterest in
things she had previously enjoyed: cooking, sewing, and shopping. She proceeded to
describe the following scenario,
“We call it the happy pill. We take that once a day. My husband was in the
convalescent home, they put him on it and he seemed so changed with it…they
called it the happy pill. When I went to my doctor, I had no interest in anything…
so I asked the doctor, ‘do you think the happy pill would work for me?’ and it
did.”
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Chapter 5
Introduction
This final chapter will present a summary of findings with discussion of pertinent
published research. Limitations will be examined. Finally, implications for nursing
education, research, and practice will be presented.
Discussion
Summary of Findings
Patients living with HF find themselves in a complex world. The average age of
patients in this study was 81± 8 and they took an average of 12.6 medications, many with
multiple dose times. All patients reported at least five medications, a burden that
increases the risk of adverse drug side effects as well as cost (Budnitz, Lovegrove,
Shehab, & Richards, 2011; Gnjidic, Le Couteur, Kouladjian, & Hilmer, 2012; ObreliNeto et al., 2012). The average computed ActualMeds™ risk score of the patients
sampled was high, 63 ± 31. Most (71%) were prescribed medications not recommended
for the gerontologic population (AGS, 2012). Patients recognized cognitive changes and
of the patients reporting AGS (2012) medications, 18% had fallen within the last year.
Others reported a myriad of associated symptoms including unsteadiness, memory
change, constipation, and urinary incontinence.
Of the patients prescribed medications contraindicated in the elderly population,
71% were prescribed at least one and 51% had two or more (AGS, 2012). Patients
prescribed these medications reported a 48% incidence of related side effects.
Polypharmacy was pervasive, often with multiple prescribers, and OTCs accounted for
29% of medications reported. Although there are no Healthcare Effectiveness Data and
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Information Set (HEDIS) performance measures specific to HF, there are HEDIS
measures for use of high-risk medications in the elderly (NCQA, 2014). The measures
include the percentage of Medicare members, 65 years of age and older who were
prescribed at least one high-risk medication and the percentage of patients who received
at least two different high-risk medications. For both measures, lower rates represent
better performance. HF is the most frequent cause of hospitalization; HEDIS measures
should be developed for this diagnosis.
Of the patients surveyed, two-thirds reported discrepancies with their medication
record from the Home Care agency. Most of these were due to patient recovery from an
acute HF episode hospitalization or from other cause hospitalization and medications
were no longer required. Some overlap was noted and one-third of patients reported
taking medication not on their medication record. These included changes to the HF
medication regime and OTCs, including NSAIDs and antihistamines. One patient
reported a potentially harmful misunderstanding of his discharge instructions and had
stopped taking his HF medications.
All of these patients would benefit from a medication therapy review by a nurse,
pharmacist, or eligible provider (EP) at the time of discharge from the hospital and again
during home health care treatment to address regime adherence to ACC guidelines and
minimize the number of prescribed Beers medications. In addition, these results
demonstrate that following discharge from home health, patients living with HF require
medication oversight of their regime. According to Centers for Medicare and Medicaid
Services (CMS, 2013), the EP who receives a patient from another setting of care or
provider of care should perform medication reconciliation. CMS also recommends
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reconciliation during transitions of care, such as upon hospitalization and discharge to
home. In this study, patients were contacted at least two weeks following discharge from
home care. Contacting patients one-week post discharge would provide the prescribing
team (EP, nurse, and pharmacist) a good assessment of changes patients are making to
their regime and be early enough to prevent complications. At that point the nurse or
pharmacist would be able to reinforce rationales for the prescribed regime. Furthermore,
when prescribers discontinue or add new medications, a member of the prescribing team
should reconcile the medication regime.
Self-efficacy theory has demonstrated its usefulness with medication adherence in
the gerontologic population and it provides four sources for interventions to improve a
patient’s self-medication practices. However, caution must be used because patients may
demonstrate a false sense of confidence to providers who don’t have the time required to
delve into issues in the patient’s self-medication practices. The current system in which
patients return to the provider within one week of discharge is failing. Ultimately, due to
the dire effects of polypharmacy on the gerontologic patient, routine reconciliation and
assessment of the medication profile is required. These results from patients with HF
support the current CMS recommendation; however, these data reinforce the need for
continued diligence after transition.
Anticholinergic Risk
Despite high levels of confidence in their management of their regime, patients
admitted to a plethora of errors, most often because they didn’t remember. Potential risk
factors for cognitive impairment include anticholinergic drug use and age (Ancelin et al.,
2006; Roe, Anderson, & Spivack, 2002). Ancelin et al. (2006) found the only highly
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significant predictors of mild cognitive impairment were anticholinergic drug use (p <
0.001) and age (p < 0.001) after adjustment for other possible causes. Again, 71% of the
patients interviewed in this study were prescribed at least one medication contraindicated
for the older adult and 51% reported two or more (AGS, 2012). AGS (2012) provides
alternative medications for all medications that have high anticholinergic effects in older
adults.
A stunning 95% of patients surveyed in this study were taking medications with
anticholinergic side effects and risk of cognitive impairment. Seventy-eight percent had
at least a moderate anticholinergic burden (ACB) score (2 or more) and 54% had a high
anticholinergic burden score (≥ 3, range 3-10). It is recommended that patients be
prescribed medications with lower levels of anticholinergic activity; however, it warns
that patients prescribed multiple medications with lower levels of activity would be at
risk for cumulative effects. Also, patients prescribed a single medication with higherlevel activity would be at risk when self-medicating with OTCs with anticholinergic
activity such as loperamide, ranitidine, cimetidine, diphenhydramine, clemastine, and
cetirizine.
Patients with HF are placed in a difficult situation because the HF medication
guidelines (ACC, 2013) include medications that carry mild cholinergic burden. As seen
in this study, patients may be prescribed multiple medications according to these
guidelines that engender an anticholinergic burden. Two of the most commonly
prescribed medications for the patients, metoprolol and furosemide, both yield a mild
ACB. Carvedilol has no associated ACB and would be a better choice for patients with
HF. If the patient also has atrial fibrillation and is prescribed warfarin, the patient already
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carries a high burden (ACB=3). Because of the compounding effects of additional
medications, the regime warrants review at times of transition, within one week of
discharge from the hospital and/ or home care, and again at a minimum of every two
months. These reviews require continuity and should be conducted with ongoing
assessment of symptoms and education around the importance of adherence to their
regimen and avoidance of adverse self-medication behaviors, particularly with OTCs on
the Beers list. Phone interventions could be warranted more often in patients with highrisk scores, or high anticholinergic burden, and/ or taking Beers medications (AGS, 2012)
and should be investigated in future research.
Clinical Implications
Other variables to consider when assessing patients for increased risk are those who
live alone and report poor health. Iloabuchi, Deming Mi, Wanzhu, and Counsell (2014)
identified independent risk factors of early readmission to the hospital were living alone
and poor communication with the primary care provider (PCP). Older adults living alone
were at greater risk of decompensation (Iloabuchi, et al., 2014). Other risk factors for
poor self-care care regime identified by Iloabuchi et. al (2014) include <12 years of
education, and poor satisfaction with primary care provider. Berner (2012) describes the
need for greater numbers of geriatricians who understand the time required to foster and
build confidence in the relationship with the aging patient. Geriatric nurse practitioners
(NP) could fill the void in number of geriatricians. Once again, a prescribing team would
be the most beneficial to the patient due to the complexity of the regime of the older adult
with HF. Pharmacists certified in geriatric pharmacy working in tandem with the HF
nurse and the EP need to collaborate to minimize risk associated with the prescribed
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regime. Ultimately, it is evident that medication review cannot be left to a primary care
visit with a median time of 14 minutes in duration (Hing, Cherry, & Woodwell, 2006).
The average length of the focused interview on medications in this study was 15 minutes.
A solution such as ActualMeds™ would facilitate seamless workflow between the entire
prescribing team and afford the opportunity for productive dialogue during patient visits
with the PCP.
Not only are geriatricians necessary to build the relationship with the patient, they
would be knowledgeable of the medications not recommended for this population. In this
study, patients were prescribed many different medications contraindicated by the AGS
(2012). Finally, 6 of the 10 patients who reported cognitive changes and other side effects
of anticholinergic medications reported lower self-efficacy.
Depression
Furthermore, depressive symptoms have been identified as an independent risk
factor for mortality in the elderly (Teng, Yeh, Lee, Lin, & Lai, 2013). The incidence of
depression in HF is well documented (Bekelman et al., 2007; Delaney & Apostolidis,
2010; Jaarsma, Johansson, Agren, & Stromberg, 2010). Depression is reported in up to
60%-78% of patients living with HF, depending on the method of measurement.
Nonadherence to medication was reported in 25-35% of HF patients who reported
depression and anxiety (Wu, 2008). Sadly, often patients living with HF are not offered
psychosocial consultations (Ryan & Farrelly, 2009). Patients cannot perform as they once
did. Regime restrictions impose constraints on the patient’s ability to interact outside of
the home. Expressions of grief were common due the frustrations of the patient’s current
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health status. Of patients who reported depression, 3 of the 5 had lower OESE scores and
all 6 who reported anxiety had lower OESE scores. Only one patient in this study
admitted that he was offered psychosocial services.
Case Highlights
A patient living with her husband had multiple comorbid conditions and was
prescribed 2 medications with strong anticholinergic effects. She reported depression and
had a high calculated risk score. She wasn’t totally confident that her medications were
improving the quality of her life; however with the reported high MSE scores, a provider
might find it difficult in a brief visit to uncover the issues with the patient’s regime.
Sadly, as made evident in the words of patients with lower SE scores presented
within, too many patients’ experiences with HF end in Despair (Erikson, 1997). Patients
described discontentment with the restrictions of the imposed medication regime.
Another patient confided that her regime had been to take 80 mg of Lasix in the morning;
however, her PCP changed her prescription to 40 mg in the morning and 40 mg in the
afternoon. She confessed she could no longer leave the house for fear of a bladder
accident. Many patients reported similar restrictions and with similar dismay.
Unfortunately, it is avoidance that intensifies deterioration in physical conditioning (Pihl,
Fridlund & Mårtensson, 2011). The patient stated she had not reported her dissatisfaction
regarding the change in regime to her PCP, but rather wouldn’t take the second dose if
there were something that required she leave her home.
There were 6 patients whose interviews yielded very high-risk scores. An 80-yearold woman, who lived alone, was prescribed 11 medications, 6 of these with mild
anticholinergic burden and 2 were Beers medications (AGS, 2012). In addition, she took
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5 OTC medications, one of which contributed further anticholinergic burden (ACB = 7).
Both her MSE and OESE scores were lower. Another man on 21 medications, 2 with low
anticholinergic burden and 3 other Beers medications, reported anxiety, DM, and HF
described his health as poor. Because he lived with his wife and she helped him with his
medications he reported confidence in his medication regime; however he reported very
low scores in OESE. Another man, who reported comorbid conditions of emphysema and
depression, had a total risk score of 155. He was prescribed 12 medications, 4 with
anticholinergic side effects (total ACB score = 4) one additional Beers medication, and he
self-medicated with 4 OTC medications. He lived alone and used no adherence tool, yet
he reported high MSE, but very low OESE scores. Finally, another gentleman with a very
high calculated risk score (137) reported 21 medications, 8 with multiple dose times
(ACB = 3; Beers medications – 2). He lived with his wife, used an adherence tool, and
reported good support systems. He reported confidence in his MSE. His comorbid
conditions included DM and depression. Sadly, he had very little confidence in his
medications’ ability to improve his life. The combination of reported SE measures, highrisk scores, and words uncover the precarious state that many patients living with HF
function within.
It is evident from the summary of data that living alone, advancing age,
medications contraindicated by AGS (2012), a history of depression or anxiety, low MSE
and/ or OESE scores, and a calculated ActualMeds™ high risk score operate as barriers
to successful transition for these patients. Captured together, these data paint a more clear
illustration into the patient’s transition (Meleis, et al., 2000) to living with HF.

PATIENTS AND HEART FAILURE MEDICATIONS

72	
  	
  

Strengths
The design of this study had several strengths. Due to the complexity of the
regime required for successful management of daily self-care in patients living with HF,
the mixed-methods design afforded the opportunity to collect data from multiple
perspectives to capture a more complete understanding of the process. The pragmatic lens
enabled the threading of the objective/ subjective realm to the inductive/ deductive one.
There were enough patients with both lower and higher MSE and OESE scores
for the qualitative interviews to yield rich data that provided vivid descriptions of the
patients’ perceptions of their imposed regime. Patients were interviewed over the phone
at their convenience. The patients remained anonymous and would be honest in their
answers.
Limitations
The limitations in this study include its small sample size with participants from
one home care agency in Central Connecticut. Due to the small sample size, sufficient
power was not reached to find significance in the differences in OESE between males and
females and correlations between OESE and risk scores. Although age and education
were normally distributed, most patients were Caucasian. In addition, no instrument was
used to measure cognitive function at baseline. While the demographics (Caucasion with
> 50% reporting high school education) of this sample has been cited as a limitation, the
findings are worrisome. This sample might be considered the best-case scenario because
of the patients’ level of education, their access to care, and the sample patients
volunteered for the study. Patients who live alone with low literacy/ numeracy skills and
poor cognitive functioning must be considered.
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Finally, patients may have felt obliged to report high levels of confidence in their
regime. Social desirability and its influence on participant responses have been identified
in the literature (Osborne, Middleton, Jones, Ford, & Noble, 2013; Reese et al., 2013).
While Reese et al. (2013) found that participant responses were not inflated or influenced
by the presence of the therapist, Osborne et al. (2013) question the validity of selfreported data in interviews. Future studies will continue to add to the body of evidence on
social desirability and its impact on survey responses and qualitative interviews. Two
patients in this current study stated that they knew what was expected of them.
Implications for Nursing Education and Practice
The results of this study build on the increasing body of evidence to support
continued oversight of adherence to ACC guideline recommendations (Lama Tamang et
al., 2013) and patient education following hospitalization (Crowder, 2006; Delaney et al.,
2013; Hernandez et al., 2010). Similar to Lama Tamang et al. (2013) in which 16.7% of
patients were prescribed all four of the ACC recommended classes of medications [βblockers, angiotensin converting enzyme inhibitors/angiotensin receptor blockers
(ACEIs/ARBs), diuretics, and digoxin], the patients interviewed for this study were
prescribed all four at a rate of 17%. Unlike Lama Tamang where 83.3% of patients were
taking only one medication of the recommended 4-drug regimen, a majority of patients in
this study were taking more than one medication (88%).
Additionally, this study highlights the necessity of seamless communication
between the health care team in an effort to prevent the potential harmful effects of
polypharmacy. This study illustrates the compounding risks of prescribed and OTC
medications either from a gerontologic or anticholinergic burden perspective. Despite
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patients’ high levels of confidence in their management of their regime, they asked a
myriad of questions during the interviews and confessed to errors.
HF is a complex etiology that requires patients to expertly manage multiple
therapeutic regimes simultaneously. Nurses require education to provide this information
to patients prior to discharge. Failure to properly manage these increases the risk of
adverse drug events, exacerbation of HF and increased rates of rehospitalization.
Ultimately, care within our current system is driven by health care costs. The
medicalization of care attempts to describe quality of life in rehospitalization statistics,
complication rates, and severity of disease. Because of the exorbitant costs related to
these, nursing has a unique opportunity. By entering an engaged relationship, coaching
patients on the telephone or visiting patients in their home, interventions designed to
facilitate successful management of the patient’s regime have the potential for a sustained
effect. Research aimed at the four sources of knowledge in self-efficacy and to allay
inhibitors of a successful transition requires immediate attention.
Operationalized within the population living with HF, it is proposed that with the
presence of an engaged nursing relationship, the process of transitioning to living with
the sequelae is optimized. Meleis et al. (2000) advocates multiple realities can exist
within the experience of a phenomenon. Transitions are complex, operating within the
fabric of society, and cannot be interpreted in isolation. She concludes transitions exist
along a continuum resulting both from and in change. These underlying assumptions
seem compatible with patients diagnosed with HF transitioning to living with that
diagnosis.
Meleis et al. (2000) includes in her theory of transition, properties of the transition
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experience: awareness, engagement, change and difference, time span, and critical points
or events. Once again, they are interrelated properties of a complex process. When
patients have a new diagnosis, it is considered a critical point in which they are
confronted with barriers and supported by facilitators. Engagement is relevant to HF
patients, defined as the degree to which a person embraces in the process required to
transition (Meleis et al., 2000). It includes a patient’s seeking health information, using
role models, and modifying activities. It is within engagement that nursing has an
opportunity to improve patients’ self-efficacy and quality of life.
This presents an enormous opportunity for nurses to facilitate a positive transition
through a relationship of support and creativity. We know that providing patients with
information or therapeutic interventions does not always change behavior. Schroeder
(2003) suggests that relationship in nursing is an outcome itself. With this approach, there
is a continued negotiation between the nurse and the patient. It is within the relationship
and the dialogue between the nurse and patient that engagement occurs. When carefully
“co-constructed,” the environment becomes a safe haven for the patient and the nurse to
explore together. The nurse would come to know the subtleties of change demonstrated
by a patient. Early recognition might afford the avoidance of the barriers and facilitation
of optimized wellness. Presented with success, patients would have increased selfefficacy expectations and outcome expectations. Patients would have the opportunity to
remain engaged. As their lives change, the sustained relationship may facilitate patients
to maintain connections. Research to enhance positive relationships and to allay
inhibitors of a successful transition are needed.
Implications for Nursing Research
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Programs such as The Care Transitions Program (Coleman, 2014) present a
successful option for patients with fewer support systems. This program was developed
through the University of Colorado School of Medicine and is a division of Health Care
Policy and Research. It aims to support patients through transitions and increase skills
among healthcare providers by enhancing health information technology and
implementing system level interventions to improve the quality of care. One instrument
that might prove beneficial for the population in this study is the Medication Discrepancy
Instrument (Coleman, 2014). The elements in this tool include the causes and
contributing factors related to adherence across the spectrum: patient level, system level,
and resolution level. It has been previously validated and is widely used.
Another interdisciplinary program whose aim is to minimize disparities among
vulnerable community-based elder populations is the Transitional Care Model, a nurseled, team-based care delivery model that focuses on providing synchronous delivery of
care among disciplines (Naylor, 2004). It calls for enhanced patient engagement with a
focus on barriers to elders along with shared decision-making in resolution (Naylor,
Hirschman, O'Connor, Barg, & Pauly, 2013). The Hospital Discharge Screening Criteria
for High Risk Older Adults instrument could address the need to establish those at
greatest risk at the time of discharge (Bixby & Naylor, 2009). The assessment of this
instrument would assist nurses in the identification of those in need and trigger post
discharge interventions to insure coordination of care to those at risk after discharge. The
TCM responds to the greatest threats to our health care system: the increasing numbers of
chronically ill elderly patients generating a disproportionate amount of health care
expenditures (Naylor, 2012).	
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Future studies must incorporate a cognitive assessment instrument to assess
cognitive impairment in order to provide data to support conclusions related to the
participant’s ability to manage his or her regime. Cai, Campbell, Khan, Callahan, and
Boustani, (2013) demonstrated that anticholinergic medications in the gerontologic
population may be a risk factor for developing mild cognitive impairment. Monitoring of
these medications used in the HF population is warranted.
A report released by the National Alliance for Caregiving and the American
Association for Retired Persons (2004) estimates that 22.9 million American families or
44.4 million individuals are involved in caring for a person over the age of 50 (Sanford,
Townsend-Rocchicciolli, Horigan, & Hall, 2011). High caregiver burden is associated
with increased need for assistance (Garlo, O’Leary, Van Ness, & Fried, 2010). Clark,
Reid, Morrison, Capewell, Murdoch and McMurray (2008) studied the complexity of
informal care of patients with HF and concluded that future interventions must include
caregivers in order to improve quality of care and reduce escalating health care costs.
High-level social caregiver support in Stage III HF patients improves communication
with the primary care provider and overall self-care practices (Galleger, Luttik, &
Jaarsma, 2011). These studies highlight the importance of enabling caregivers to make
the best decisions related to caring for the patient with HF.
Symptoms associated with HF in community-dwelling adults and older adults
have been shown to be a source of concern as well as support among their family
members. As supported in this study, family caregivers have been shown to play
important roles in facilitating HF patients’ adherence to complex medication regimens,
promoting patients’ self-care behavior, and monitoring HF symptoms. Family support has
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been associated with improved self-care among HF patients (Dunbar, et al, 2008);
however, these roles can weigh heavily on caregivers. Family caregiver burden levels
have been found higher when the physical health of their relative with HF is more
impaired, even after controlling for caregiver knowledge about HF and perceived control
over their relatives’ cardiovascular health (Agren, et al, 2010). Recently published
qualitative research with family caregivers of HF patients has shown that many
caregivers are unprepared to manage the disease burden without consistent information
and assistance by health care professionals (Imes, et al, 2011). In 2006, the HF Society
of America recommended that HF care improvement should include assessment and
intervention of needs among both patients and family caregivers (HFSA, 2006).
Finally, a model for the triadic relationship between the patient, caregiver, and
primary care provider would enable the measurement of the impact of these important
variables on the patient’s adherence and understanding of his regime (Fortinsky, 2001).
Following discharge from the hospital or home care, a phone interview conducted by a
nurse would identify risks that could lead to rehospitalization. Self-medication and other
patient reported status (symptoms, sleep patterns, etc.) would provide early insight into
care gaps and possible interactions. Finally, communication of Action Plans from risk
assessment of the ActualMeds™ instrument would have the potential for use in care
coordination system-wide for high risk cohorts with complex regimens.
Improving the transitions in living with HF is critical in the effective treatment of
the disease. Strategies aimed at facilitating supportive care to those diagnosed with HF
would ultimately improve the quality of life in this population. Presented with success
patients would have increased self-efficacy expectations and outcome expectations.
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Patients would have the opportunity to remain engaged. As their lives change, facilitators
are required to assist patients to maintain connections. Research to enhance positive
relationships and to allay inhibitors of a successful transition is needed. Barriers to a
positive transition cannot be ignored. Patients living alone are at risk and depression
remains underdiagnosed and undertreated. Effective strategies would focus on patient
concerns and perhaps require gender specificity. The goal to decrease adverse sequelae
from medication interactions and improve how patients feel would be observed.
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Table 1
Baseline characteristics of HF symptoms
Characteristic

Diastolic (HFpEF)

Systolic (HFrEF)

Diagnosis
Gender
HF Guideline Evidence

Preserved LV function
Greater in women
Small studies
Level C

Impaired LV function
Greater in men
RCTs
Level A & B

Symptoms

Overwhelming fatigue
Chest Pain
Shortness of breath
Edema
Treat comorbid conditions
Optimize LV function
Patients sensitive to volume changes Diuresis
Caution with diuresis

Treatment
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Table 2
Principal-Component Analysis with Oblique Rotation (N = 93)
Item
Stem
Number
Factor I
Confidence
12
Keep you out of the hospital
Medications will
15
Make you feel better
have prescribed
14
Lead a normal life
effect
10
Improve your health
13
Live a long life
11
Improve your quality of life
Factor II
Medication
7
When you are interrupted
Adherence with
6
When you are busy
Disruption
4
When you are sad
9
When no one reminds you
Factor III
Confidence that
3
You have an upset stomach
you will take
2
You have pain
medications
1
You have a cold
correctly when…
5
You take vitamins
8
The drug is expensive

Table 3
Pattern Matrix Oblique Rotation* (N=93)
Item
Factor I
Factor II Factor III
12
0.97
15
0.95
14
0.95
10
0.95
13
0.94
11
0.94
7
0.96
6
0.93
4
0.78
9
0.51
3
0.92
2
0.88
1
0.86
5
0.70

Loading
0.97
0.95
0.95
0.95
0.94
0.94
0.96
0.93
0.78
0.51
0.92
0.88
0.86
0.70
0.51
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8
0.51
*For ease of interpretation only entries above 0.30 have been included. Items are sorted
by loadings in descending order.
	
  

Table 4
Inter-correlation Matrix Oblique Rotation: (N=93)
Component

1

2

3

1

1.000

0.31

0.57

2

0.31

1.000

0.51

3

0.57

0.51

1.000

	
  
	
  
	
  
	
  

Table 5
Baseline characteristics of patient population
Characteristic
Sex
Female
Male
Race
Caucasian
African American
Last year of completed education
10th grade
12th grade
14 years
16 years
18 years

Frequency

Percent

24
17

58.5
41.5

39
2

95.1
4.9

6
22
2
10
1

14.6
53.7
4.9
24.4
2.4

100	
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Number of medications
5 – 9 medications
10 – 14 medications
15 – 19 medications
20 – 26 medications
Self-health rating
Very good
Good
Average
Fair
Poor
Depressive symptoms
Anxiety
Anxiety, Depression
None
	
  
	
  
	
  
Table 6

8
19
4
4

22.9
54.2
11.5
11.5

4
11
5
8
6

11.1
30.6
13.9
22.2
16.7

7
5
22

19.4
13.9
61.

Self-reported comorbid conditions
Frequency
	
  
Hypertension
Diabetes Mellitus
Chronic obstructive pulmonary disease
asthma, or emphysema	
  

23
11
9

Percent
56
27
22

Table 7
Self-reported medication use
Medication category
	
  
Diuretic
Beta blocker
Angiotensin converting enzyme inhibitor
Aspirin
Anticoagulant
Calcium channel blocker
Angiotensin receptor blocker
	
  
	
  
	
  

Frequency
26
25
8
16
13
7
5

Percent
62
61
20
39
32
17
10
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Table 8
Mean self-efficacy, risk score, and BP values
Characteristic

Mean

SD

	
  
Age in years
Mean self-efficacy
Outcome expectations
ActualMedsTM risk score
Systolic blood pressure
Diastolic blood pressure

81.1
3.9
4.01
62.6
123.4
64.6

8.5
1.1
1.0
50.6
20.5
13.0

	
  
Table 9
Beers medications reported and number of patients prescribed each
Medication

Alpha blockers
terazosin
Antispasmodics
dicyclomine
Antidysrhythmics
sotalol
Antimuscarinics
oxybutynin
Antithrombotics

Brand Name

Number of
patients
prescribed

Hytrin

	
  

2	
  

Bentyl

	
  

2	
  

	
  

1	
  

	
  

1	
  

Ditropan
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Medication

dabigatran
rivaroxaben
Tertiary TCAs
amitriptyline
Benzodiazepines
alprazolam
lorazepam
Cardiovascular medications
sotalol
spironolactone
Endocrine estrogens
estradiol
Endocrine sulfonylureas
glimepiride
glipizide
Insulin sliding scale
Insulin
Nonbenzodiazepine hypnotics
zolpidem
eszopiclone
Non-COX NSAIDS
ibuprofen
Oral decongestants
methylphenidate
Skelatal muscle relaxants
cyclobenzaprine
metaxalone
Seizure medications
nortriptyline
tramadol
SSRIs
citalopram
escitalopram oxalate
sertraline
Thyroid medication

Brand Name

Number of
patients
prescribed
3	
  
1	
  

Pradaxa
Xarelto
	
  

1	
  

Xanax
Ativan

	
  

7	
  
1	
  

Betapace
Aldactone

	
  

1	
  
6	
  

Estrace

	
  

1	
  

Ameryl
Glucotrol

	
  

1	
  
1	
  

Regular

	
  

7	
  

Ambien
Lunesta

	
  

2	
  
1	
  

Advil

	
  

4	
  

Ritalin

	
  

1	
  

Flexeril
Skelaxin

	
  

2	
  
1
2	
  
3	
  

Tegretol
Ultram
Celexa
Lexapro
Zoloft

	
  

4	
  
3	
  
1	
  

ArmourThyroid

	
  

1	
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Table 10
Anticholinergic medications reported and number of patients reporting each
ACB Score 1

alprazolam
atenolol
codeine
colchicine (OTC)
digoxin
diltiazem
fluticasone

ACB Score 2

5
2
5
1
3
1
2

carbamazepine
cyclobenzapine
cetrizine
loratadine

ACB Score 3

1
1
1
1

amitriptyline
dicyclomine
diphenhydramine
nortriptyline
oxybutynin
paroxetine

1
1
1
1
1
1
1
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ACB Score 1
furosemide
isosorbide
loperamide
(OTC)
lorazepam
metoprolol
mirtazepine
prednisone
ranitidine (OTC)
sertraline
tramadol
	
  
warfarin
	
  
	
  
	
  
	
  
	
  

Figure 1
Self-Efficacy model

ACB Score 2

ACB Score 3

27
1
1
13
1
4
4
1
3	
  
12	
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Figure 2
Convergent parallel mixed methods design
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Figure 3
HF medication self-efficacy instrument
Please rate the following statements on a scale of:
1 (not at all confident) to 5 (totally confident)
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How confident are
you that you take
your prescription
medication correctly
when...
1. you have a cold.
2. you are having pain.
3. you are taking
medication for an upset
stomach.
4. you are feeling sad.
5. you are taking your
vitamins.
6. you have a busy day.
7. your normal routine is
interrupted.
8. the drug is expensive.
9. when no one reminds
you to take your
medication.

Not at all
confident

Totally
confident

1
1

2
2

3
3

4
4

5
5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

4

4

5

1

2

3

4

5

1

2

3

4

5

10. improve your health.
1
11. improve your quality
1
of life.
12. keep you out of the
1
hospital.
13. allow you to live a
1
long life.
14. allow you to live a
1
near normal life.
15. make you feel
1
better.
Please provide this information about you:

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

Do you take medications for your heart?

Yes or

How confident are
you that your
medication will...

Figure 4
Histogram of risk scores

Age:_______
No

Gender: M or F
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Figure 5
Number of medications correlated to risk score
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Outcome expectations correlated to risk score
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